Immunopathogenesis of oropharyngeal candidiasis in human immunodeficiency virus infection

Clinical Microbiology Reviews

Volumn 17, Issue 4, 2004, Pages 729-759

  De Repentigny, Louis ^a,b   Lewandowski, Daniel ^a   Jolicoeur, Paul ^c  

^a UNIVERSITÉ DE MONTRÉAL   (Canada)

^b UNIVERSITY OF MONTREAL   (Canada)

^c CLIN RESEARCH INSTITUTE OF MONTREAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; CALPROTECTIN; CD4 ANTIGEN; CD8 ANTIGEN; PROTEINASE INHIBITOR;

CANDIDA ALBICANS; CANDIDIASIS; CLONAL VARIATION; DISEASE COURSE; ESOPHAGUS DISEASE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HOST RESISTANCE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOPATHOGENESIS; KERATINOCYTE; LANGERHANS CELL; LYMPHOCYTE SUBPOPULATION; OROPHARYNX; PATHOGENESIS; PHAGOCYTE; REVIEW; TRANSGENIC MOUSE;

AIDS-RELATED OPPORTUNISTIC INFECTIONS; ANIMALS; CANDIDA; CANDIDIASIS, ORAL; HUMANS; IMMUNITY, NATURAL; OROPHARYNX;

ANIMALIA; CANDIDA; CANDIDA ALBICANS; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; MUS MUSCULUS; RNA VIRUSES;

EID: 5644233700     PISSN: 08938512     EISSN: None     Source Type: Journal    
DOI: 10.1128/CMR.17.4.729-759.2004     Document Type: Review

References (474)

1. Abgrall, S., I. Charreau, V. Joly, J. Bloch, and J. Reynes. 2001. Risk factors for esophageal candidiasis in a large cohort of HIV-infected patients treated with nucleoside analogues. Eur. J. Clin. Microbiol. Infect. Dis. 20:346-349.
2. Abi-Said, D., E. Anaissie, O. Uzun, I. Raad, H. Pinzcowski, and S. Vartivarian. 1997. The epidemiology of hematogenous candidiasis caused by different Candida species. Clin. Infect. Dis. 24:1122-1128.
3. Acierno, L. J. 1989. Cardiac complications in acquired immunodeficiency syndrome (AIDS): a review. J. Am. Coll. Cardiol. 13:1144-1154.
4. Agostini, C., and G. Semenzato. 1996. Immunologic effects of HIV in the lung. Clin. Chest Med. 17:633-645.
5. Agostini, C., R. Zambello, L. Trentin, and G. Semenzato. 1996. HIV and pulmonary immune responses. Immunol. Today 17:359-364.
6. Ahlfors, E. E., P. A. Larsson, and P. R. Bergstresser. 1985. Langerhans cell surface densities in rat oral mucosa and human buccal mucosa. J. Oral Pathol. 14:390-397.
7. Almstahl, A., U. Kroneld, A. Tarkowski, and M. Wikstrom. 1999. Oral microbial flora in Sjogren's syndrome. J. Rheumatol. 26:110-114.
8. Ammann, A. J., and R. Hong. 1971. Selective IgA deficiency: presentation of 30 cases and a review of the literature. Medicine (Baltimore) 50:223-236.
9. Anderson, D. W., and R. Virmani. 1990. Emerging patterns of heart disease in human immunodeficiency virus infection. Hum. Pathol. 21:253-259.
10. Angel, J. B., A. Kumar, K. Parato, L. G. Filion, F. Diaz-Mitoma, P. Daftarian, B. Pham, E. Sun, J. M. Leonard, and D. W. Cameron. 1998. Improvement in cell-mediated immune function during potent anti-humanimmunodeficiency virus therapy with ritonavir plus saquinavir. J. Infect. Dis. 177:898-904.
11. Anjuere, F., P. Martin, I. Ferrero, M. L. Fraga, G. M. del Hoyo, N. Wright, and C. Ardavin. 1999. Definition of dendritic cell subpopulations present in the spleen, Peyer's patches, lymph nodes, and skin of the mouse. Blood 93:590-598.
12. Anonymous. 1993. Classification and diagnostic criteria for oral lesions in HIV infection. EC-Clearinghouse on Oral Problems Related to HIV Infection and WHO Collaborating Centre on Oral Manifestations of the Immunodeficiency Virus. J. Oral Pathol. Med. 22:289-291.
13. Reference deleted.
14. Ansel, J., P. Perry, J. Brown, D. Damm, T. Phan, C. Hart, T. Luger, and S. Hefeneider. 1990. Cytokine modulation of keratinocyte cytokines. J. Investig. Dermatol. 94:101S-107S.
15. Antinori, A., A. Antinori, A. Ammassari, R. Masetti, A. De Luca, R. Murri, E. Tamburrini, and P. Magistrelli. 1995. Presumptive clinical criteria versus endoscopy in the diagnosis of Candida esophagitis at various HIV-1 disease stages. Endoscopy 27:371-376.
16. Arendorf, T. M., and D. M. Walker. 1980. The prevalence and intra-oral distribution of Candida albicans in man. Arch. Oral Biol. 25:1-10.
17. Arribas, J. R., S. Hernandez-Albujar, J. J. Gonzalez-Garcia, J. M. Pena, A. Gonzalez, T. Canedo, R. Madero, J. J. Vazquez, and W. G. Powderly. 2000. Impact of protease inhibitor therapy on HIV-related oropharyngeal candidiasis. AIDS 14:979-985.
18. Ashman, R. B. 1991. Enhancement of MHC class II antigen expression by exposure to Candida albicans. Immunol. Lett. 30:255-260.
19. Ashman, R. B., and J. M. Papadimitriou. 1995. Production and function of cytokines in natural and acquired immunity to Candida albicans infection. Microbiol. Rev. 59:646-672.
20. Atkinson, J. C., C. Yeh, F. G. Oppenheim, D. Bermudez, B. J. Baum, and P. C. Fox. 1990. Elevation of salivary antimicrobial proteins following HIV-1 infection. J. Acquir. Immune. Defic. Syndr. 3:41-48.
21. + T cell homeostasis and function in advanced HIV disease. Science 277:112-116.
22. Autran, B., G. Carcelaint, T. S. Li, G. Gorochov, C. Blanc, M. Renaud, M. Durali, D. Mathez, V. Calvez, J. Leibowitch, C. Katlama, and P. Debre. 1999. Restoration of the immune system with anti-retroviral therapy. Immunol. Lett. 66:207-211.
23. Babas, T., E. Vieler, D. A. Hauer, R. J. Adams, P. M. Tarwater, K. Fox, J. E. Clements, and M. C. Zink. 2001. Pathogenesis of SIV pneumonia: selective replication of viral genotypes in the lung. Virology 287:371-381.
24. Bacci, A., C. Montagnoli, K. Perruccio, S. Bozza, R. Gaziano, L. Pitzurra, A. Velardi, C. F. d'Ostiani, J. E. Cutler, and L. Romani. 2002. Dendritic cells pulsed with fungal RNA induce protective immunity to Candida albicans in hematopoietic transplantation. J. Immunol. 168:2904-2913.
25. Bakri, Y., C. Schifler, V. Zennou, P. Chameau, E. Kahn, A. Benjouad, J. C. Gluckman, and B. Canque. 1920. The maturation of dendritic cells results in postintegration inhibition of HIV-1 replication. J. Immunol. 166:3780-3788.
26. Balish, E., H. Filutowicz, and T. D. Oberley. 1990. Correlates of cell-mediated immunity in Candida albicans-colonized gnotobiotic mice. Infect. Immun. 58:107-113.
27. Balish, E., J. Jensen, T. Warner, J. Brekke, and B. Leonard. 1993. Mucosal and disseminated candidiasis in gnotobiotic SCID mice. J. Med. Vet. Mycol. 31:143-154.
28. -/-) mice. J. Infect. Dis. 178:478-487.
29. Balish, E., T. Warner, C. J. Pierson, D. M. Bock, and R. D. Wagner. 2001. Oroesophageal candidiasis is lethal for transgenic mice with combined natural killer and T-cell defects. Med. Mycol. 39:261-268.
30. Banchereau, J., and R. M. Steinman. 1998. Dendritic cells and the control of immunity. Nature 392:245-252.
31. Barbeau, J., and N. Deslauriers. 1989. Phenotypic and functional analysis of oral mucosal macrophages. Reg. Immunol. 2:285-293.
32. Barchiesi, F., D. Arzeni, M. S. Del Prete, A. Sinicco, D. F. Falconi, M. B. Pasticci, L. Lamura, M. M. Nuzzo, F. Burzacchini, S. Coppola, F. Chiodo, and G. Scalise. 1998. Fluconazole susceptibility and strain variation of Candida albicans isolates from HIV-infected patients with oropharyngeal candidosis. J. Antimicrob. Chemother. 41:541-548.
33. Barchiesi, F., R. J. Hollis, M. Del Poeta, D. A. McGough, G. Scalise, M. G. Rinaldi, and M. A. Pfaller. 1995. Transmission of fluconazole-resistant Candida albicans between patients with AIDS and oropharyngeal candidiasis documented by pulsed-field gel electrophoresis. Clin. Infect. Dis. 21:561-564.
34. Barrett, A. W., A. T. Cruchley, and D. M. Williams. 1996. Oral mucosal Langerhans' cells. Crit. Rev. Oral. Biol. Med. 7:36-58.
35. Barrett, A. W., D. A. Ross, and J. A. Goodacre. 1993. Purified human oral mucosal Langerhans cells function as accessory cells in vitro. Clin. Exp. Immunol. 92:158-163.
36. Barron, M. A., N. Blyveis, B. E. Palmer, S. MaWhinney, and C. C. Wilson. 2003. Influence of plasma viremia on defects in number and immunophenotype of blood dendritic cell subsets in human immunodeficiency virus 1-infected individuals. J. Infect. Dis. 187:26-37.
37. Basson, N. J. and C. W. van Wyk. 1996. The establishment of a community of oral bacteria that controls the growth of Candida albicans in a chemostat. Oral Microbiol. Immunol. 11:199-202.
38. Beausejour, A., D. Grenier, J. P. Goulet, and N. Deslauriers. 1998. Proteolytic activation of the interleukin-1beta precursor by Candida albicans. Infect. Immun. 66:676-681.
39. Bektic, J., C. P. Lell, A. Fuchs, H. Stoiber, C. Speth, C. Lass-Florl, M. Borg-von Zepelin, M. P. Dierich, and R. Wurzner. 2001. HIV protease inhibitors attenuate adherence of Candida albicans to epithelial cells in vitro. FEMS Immunol. Med. Microbiol. 31:65-71.
40. + lymphocytes. J. Immunol. 154:5273-5281.
41. Bikandi, J., M. D. Moragues, G. Quindos, L. Polonelli, and J. Ponton. 2000. Influence of environmental pH on the reactivity of Candida albicans with salivary IgA. J. Dent. Res. 79:1439-1442.
42. Bistoni, F., E. Cenci, A. Mencacci, E. Schiaffella, P. Mosci, P. Puccetti, and L. Romani. 1993. Mucosal and systemic T helper cell function after intragastric colonization of adult mice with Candida albicans. J. Infect. Dis. 168:1449-1457.
43. Blank, C., C. Bogdan, C. Bauer, K. Erb, and H. Moll. 1996. Murine epidermal Langerhans cells do not express inducible nitric oxide synthase. Eur. J. Immunol. 26:792-796.
44. Blauvelt, A., M. Clerici, D. R. Lucey, S. M. Steinberg, R. Yarchoan, R. Walker, G. M. Shearer, and S. I. Katz. 1995. Functional studies of epidermal Langerhans cells and blood monocytes in HIV-infected persons. J. Immunol. 154:3506-3515.
45. Blumberg, H., D. Conklin, W. F. Xu, A. Grossmann, T. Brender, S. Carollo, M. Eagan, D. Foster, B. A. Haldeman, A. Hammond, H. Haugen, L. Jelinek, J. D. Kelly, K. Madden, M. F. Maurer, J, Parrish-Novak, D. Prunkard, S. Sexson, C. Sprecher, K, Waggie, J. West, T. E, Whitmore, L. Yao, M. K. Kuechle, B. A. Dale, and Y. A. Chandrasekher. 2001. Interleukin 20: discovery, receptor identification, and role in epidermal function. Cell 104:9-19.
46. Bober, L. A., T. A. Waters, C. C. Pugliese-Sivo, L. M. Sullivan, S. K. Narula, and M. J. Grace. 1995. IL-4 induces neutrophilic maturation of HL-60 cells and activation of human peripheral blood neutrophils. Clin. Exp. Immunol. 99:129-136.
47. Bolduc, C., J. D. Waterfield, and N. Deslaurlers. 1990. Tissue distribution and cytofluorometric analysis of oral mucosal T cells in the BALB/c mouse. Res. Immunol. 141:461-475.
48. Borg, M., and R. Ruchel. 1988. Expression of extracellular acid proteinase by proteolytic Candida spp. during experimental infection of oral mucosa. Infect. Immun. 56:626-631.
49. Bos, I. R., and A. Burkhardt. 1980. Interepithelial cells of the oral mucosa. Light and electron microscopic observations in germfree, specific pathogen-free and conventionalized mice. J. Oral Pathol. 9:65-81.
50. Bos, J. D., I. Zonneveld, P. K. Das, S. R. Krieg, C. M. van der Loos, and M. L. Kapsenberg. 1987. The skin immune system (SIS): distribution and immunophenotype of lymphocyte subpopulations in normal human skin. S. Investig. Dermatol. 88:569-573.
51. Brady, H. J., D. J. Pennington, and E. A. Dzierzak. 1994. Transgenic mice as models of human immunodeficiency virus expression and related cellular effects. J. Gen. Virol. 75:2549-2558.
52. Brady, H. J., D. J. Pennington, C. G. Miles, and E. A. Dzierzak. 1993. CD4 cell surface downregulation in HIV-1 Nef transgenic mice is a consequence of intracellular sequestration. EMBO J. 12:4923-4932.
53. Brambilla, A. M., A. Castagna, B. Nocita, H. Hasson, E. Boeri, F. Veglia, and A. Lazzarin. 2001. Relation between CD4 cell counts and HIV RNA levels at onset of opportunistic infections. J. Acquir. Immune Defic. Syndr. 27:44-48.
54. Brandtzaeg, P., T. O. Gabrielsen, I. Dale, F. Muller, M. Steinbakk, and M. K. Fagerhol. 1995. The leucocyte protein L1 (calprotectin): a putative nonspecific defence factor at epithelial surfaces. Adv. Exp. Med. Biol. 371A:201-206.
55. Brodt, H. R., B. S. Kamps, P. Gute, B. Knupp, S. Staszewski, and E. B. Helm. 1997. Changing incidence of AIDS-defining illnesses in the era of antiretroviral combination therapy. AIDS 11:1731-1738.
56. Brown, J. A., T. K. Howcroft, and D. S. Singer. 1998. HIV Tat protein requirements for transactivation and repression of transcription are separable. J. Acquir. Immune Defic. Syndr. Hum. Retrovirol. 17:9-16.
57. Brysk, M. M., T. Bell, H. Brysk, P. Selvanayagam, and S. Rajaraman. 1994. Enzymatic activity of desquamin. Exp. Cell Res. 214:22-26.
58. Brysk, M. M., T. Bell, C. Hoida, S. K. Tyring, and S. Rajaraman. 1991. Interferon-gamma modulates terminal differentiation and the expression of desquamin in cultured keratinocytes. Exp. Cell. Res. 197:140-147.
59. Burkhardt, A. 1992. Intraepithelial lymphocytes and Langerhans cells in the oral mucosa-dynamic aspects. J. Dent. Assoc. S. Afr. 47:200-203.
60. Calvelli, T. A., and A. Rubinstein. 1990. Pediatric HIV infection: a review. Immunodefic. Rev 2:83-127.
61. Canny, G., O. Levy, G. T. Furuta, S. Narravula-Alipati, R. B. Sisson, C. N. Serban, and S. P. Colgan. 2002. Lipid mediator-induced expression of bactericidal/permeability-increasing protein (BPI) in human mucosal epithelia. Proc. Natl. Acad. Sci. USA 99:3902-3907.
62. + hematopoietic progenitor cells is primarily determined by their maturation stage. Blood 93:3866-3875.
63. Cantorna, M. T., and E. Balish. 1990. Mucosal and systemic candidiasis in congenitally immunodeficient mice. Infect. Immun. 58:1093-1100.
64. + lymphocytes in resistance to mucosal candidiasis. Infect. Immun. 59:2447-2455.
65. Cassone, A., F. De Bernardis, A. Torosantucci, E. Tacconelli, M. Tumbarello, and R. Cauda. 1999. In vitro and in vivo anticandidal activity of human immunodeficiency virus protease inhibitors. J. Infect. Dis. 180:448-453.
66. Cassone, A., C. Palma, J. Y. Djeu, F. Aiuti, and I. Quinti. 1993. Anticandidal activity and interleukin-1 beta and interleukin-6 production by polymorphonuclear leukocytes are preserved in subjects with AIDS. J. Clin. Microbiol. 31:1354-1357.
67. Cassone, A., E. Tacconelli, F. De Bernardis, M. Tumbarello, A. Torosantucci, P. Chiani, and R. Cauda. 2002. Antiretroviral therapy with protease inhibitors has an early, immune reconstitution-independent beneficial effect on Candida virulence and oral candidiasis in human immunodeficiency virus-infected subjects. J. Infect. Dis. 185:188-195.
68. Cauda, R., E. Tacconelli, M. Tumbarello, G. Morace, F. De Bernardis, A. Torosantucci, and A. Cassone. 1999. Role of protease inhibitors in preventing recurrent oral candidosis in patients with HIV infection: a prospective case-control study. J. Acquir. Immune Defic. Syndr. 21:20-25.
69. + hematopoietic progenitors from human cord blood differentiate along two independent dendritic cell pathways in response to granulocyte-macrophage colony-stimulating factor plus tumor necrosis factor alpha. II. Functional analysis. Blood 90:1458-1470.
70. Cenci, E., A. Mencacci, R. Spaccapelo, L. Tonnetti, P. Mosci, K. H. Enssle, P. Puccetti, L. Romani, and F. Bistoni. 1995. T helper cell type 1 (Th1)- and Th2-like responses are present in mice with gastric candidiasis but protective immunity is associated with Th1 development. J. Infect. Dis. 171:1279-1288.
71. a. Centers for Disease Control and Prevention. 1992. 1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. Morb. Mortal. Wkly. Rep. Recomm. Rep. 41:1-19.
72. Chakir, J., L. Cote, C. Coulombe, and N. Deslauriers. 1994. Differential pattern of infection and immune response during experimental oral candidiasis in BALB/c and DBA/2 (H-2d) mice. Oral Microbiol. Immunol. 9:88-94.
73. Challacombe, S. J. 1994. Immunologic aspects of oral candidiasis. Oral Surg. Oral Med. Oral Pathol. 78:202-210.
74. Challacombe, S. J., and S. P. Sweet. 1997. Salivary and mucosal immune responses to HIV and its co-pathogens. Oral Dis. 3(Suppl. 1):S79-S84.
75. Challacombe, S. J., and S. P. Sweet. 2002. Oral mucosal immunity and HIV infection: current status. Oral Dis. 8(Suppl. 2):55-62.
76. Chandra, J., D. M. Kuhn, P. K. Mukherjee, L. L. Hoyer, T. McCormick, and M. A. Ghannoum. 2001. Biofilm formation by the fungal pathogen Candida albicans: development, architecture, and drug resistance. J. Bacteriol. 183:5385-5394.
77. Chandra, J., P. K. Mukherjee, S. D. Leidich, F. F. Faddoul, L. L. Hoyer, L. J. Douglas, and M. A. Ghannoum. 2001. Antifungal resistance of candidal biofilms formed on denture acrylic in vitro. J. Dent. Res. 80:903-908.
78. Charbonnier, A. S., N. Kohrgruber, E. Kriehuber, G. Stingl, A. Rot, and D. Maurer. 1999. Macrophage inflammatory protein 3α is involved in the constitutive trafficking of epidermal langerhans cells. J. Exp. Med. 190: 1755-1768.
79. Charton-Bain, M. C., B, Terris, M. C. Dauge, C. Marche, F. Walker, O. Bouchaud, L. Xerri, and F. Potet. 1999. Reduced number of Langerhans cells in oesophageal mucosa from AIDS patients. Histopathology 34:399-404.
80. Chiani, P., C. Bromuro, and A. Torosantucci. 2000. Defective induction of interleukin-12 in human, monocytes by germ-tube forms of Candida albicans. Infect. Immun. 68:5628-5634.
81. Chlou, C. C., A. H. Groll, C. E. Gonzalez, D. Callender, D. Venzon, P. A. Pizzo, L. Wood, and T. J. Walsh. 2000. Esophageal candidiasis in pediatric acquired immunodeficiency syndrome: clinical manifestations and risk factors. Pediatr. Infect. Dis. J. 19:729-734.
82. Chou, L. L., J. Epstein, S. A. Cassol, D. M. West, W. He, and J. D. Firth. 2000. Oral mucosal Langerhans' cells as target, effector and vector in HIV infection. J Oral Pathol. Med. 29:394-402.
83. Cilla, G., T. E. Perez, J. R. Furundarena, E. Cuadrado, J. A. Iribarren, and F. Neira. 1988. Esophageal candidiasis and immunodeficiency associated with acute HIV infection. AIDS 2:399-400.
84. Clerici, M. and G. M. Shearer. 1993. A TH1→TH2 switch is a critical step in the etiology of HIV infection. Immunol. Today 14:107-111.
85. Cohen, I. S., D. W. Andersen, R. Virmani, B. M. Reen, A. M. Macher, J. Sennesh, P. DiLorenzo, and R. R. Redfield. 1986. Congestive cardiomyopathy in association with the acquired immunodeficiency syndrome. N. Engl. J. Med. 315:628-630.
86. Cohen, P. J., and S. I. Katz. 1992. Cultured human Langerhans cells process and present intact protein antigens. J. Investig. Dermatol. 99:331-336.
87. Colasante, A., S. Rosini, A. Piattelli, L. Artese, F. B. Aiello, and P. Musiani. 1992. Distribution and phenotype of immune cells in normal human gingiva: active immune response versus unresponsiveness. J. Oral Pathol. Med. 21:12-16.
88. Cole, G. T. 1996. Biochemistry of enzymatic pathogenicity factors, p. 31-65. In D. H. Howard and J. D. Miller (ed.), Human and animal relationships. Springer-Verlag KG, Berlin, Germany.
89. Coleman, D., D. Sullivan, B. Harrington, K. Haynes, M. Henman, D. Shanley, D. Bennett, G. Moran, C. McCreary, and L. O'Neill. 1997. Molecular and phenotypic analysis of Candida dubliniensis: a recently identified species linked with oral candidosis in HIV-infected and AIDS patients. Oral Dis. 3 (Suppl. 1):S96-S101.
90. Colina, A. R., F. Aumont, N. Deslauriers, P. Belhumeur, and L. de Repentigny. 1996. Evidence for degradation of gastrointestinal mucin by Candida albicans secretory aspartyl proteinase. Infect. Immun. 64:4514-4519.
91. Coodley, G. O., M. O. Loveless, and T. M. Merrill. 1994. The HIV wasting syndrome: a review. J. Acquir. Immune Defic. Syndr. 7:681-694.
92. Coogan, M. M., and S. J. Challacombe. 2000. Serum and salivary antibodies to a mycobacterial 65-kDa stress protein are elevated in HIV-positive patients and modified by oral candidiasis. Oral Microbiol. Immunol. 15:284-289.
93. Coogan, M. M., S. P. Sweet, and S. J. Challacombe. 1994. Immunoglobulin A (IgA), IgA1, and IgA2 antibodies to Candida albicans in whole and parotid saliva in human immunodeficiency virus infection and AIDS. Infect. Immun. 62:892-896.
94. Costello, C. 1988. Haematological abnormalities in human immunodeficiency virus (HIV) disease. J. Clin. Pathol. 41:711-715.
95. + T cells during experimental oral candidiasis in anti-CD4-treated mice. Immunol. Infect. Dis. 4:219-227.
96. Crowe, S. M., N. J. Vardaxis, S. J. Kent, A. L. Maerz, M. J. Hewish, M. S. McGrath, and J. Mills. 1994. HIV infection of monocyte-derived macrophages in vitro reduces phagocytosis of Candida albicans. J. Leukoc. Biol. 56:318-327.
97. Cruchley, A. T., D. M. Williams, P. M. Farthing, C. A. Lesch, and C. A. Squier. 1989. Regional variation in Langerhans cell distribution and density in normal human oral mucosa determined using monoclonal antibodies against CD1, HLADR, HLADQ and HLADP. J. Oral Pathol. Med. 18:510-516.
98. Cullell-Young, M., M. Barrachina, C. Lopez-Lopez, E. Gonalons, J. Lloberas, C. Soler, and A. Celada. 2001. From transcription to cell surface expression, the induction of MHC class II I-A alpha by interferon-gamma in macrophages is regulated at different levels. Immunogenetics 53:136-144.
99. Cumberbatch, M., R. J. Dearman, C. Antonopoulos, R. W. Groves, and I. Kimber. 2001. Interleukin (IL)-18 induces Langerhans cell migration by a tumour necrosis factor-alpha- and IL-1beta-dependent mechanism. Immunology 102:323-330.
100. Cutler, C. W., R. Jotwani, and B. Pulendran. 2001. Dendritic cells: immune saviors or Achilles' heel? Infect. Immun. 69:4703-4708.
101. Cutler, J. E. 1991. Putative virulence factors of Candida albicans. Annu. Rev. Microbiol. 45:187-218.
102. Reference deleted
103. Dahl, K. M., E. J. Keath, V. J. Fraser, and W. G. Powderly. 1997. Molecular epidemiology of mucosal candidiasis in HIV-positive women. AIDS Res. Hum. Retroviruses 13:485-491.
104. Daniels, T. E. 1984. Human mucosal Langerhans cells: postmortem identification of regional variations in oral mucosa. J. Investig. Dermatol. 82:21-24.
105. Derbyshire, J. 2000. Therapeutic interventions in HIV infection - a critical view. Trop. Med. Int. Health 5:A26-A31.
106. De Bernardis, F., S. Arancia, L. Morelli, B. Hube, D. Sanglard, W. Schafer, and A. Cassone. 1999. Evidence that members of the secretory aspartyl proteinase gene family, in particular SAP2, are virulence factors for Candida vaginitis. J. Infect. Dis. 179:201-208.
107. De Bernardis, F., M. Boccanera, D. Adriani, E. Spreghini, G. Santoni, and A. Cassone. 1997. Protective role of antimannan and anti-aspartyl proteinase antibodies in an experimental model of Candida albicans vaginitis in rats. Infect. Immun. 65:3399-3405.
108. De Bernardis, F., P. Chiani, M. Ciccozzi, G. Pellegrini, T. Ceddia, G. D'Offizzi, I. Quinti, P. A. Sullivan, and A. Cassone. 1996. Elevated aspartic proteinase secretion and experimental pathogenicity of Candida albicans isolates from oral cavities of subjects infected with human immunodeficiency virus. Infect. Immun. 64:466-471.
109. De Bernardis, F., F. A. Muhlschlegel, A. Cassone, and W. A. Fonzi. 1998. The pH of the host niche controls gene expression in and virulence of Candida albicans. Infect. Immun. 66:3317-3325.
110. De Bernardis, F., P. A. Sullivan, and A. Cassone. 2001. Aspartyl proteinases of Candida albicans and their role in pathogenicity. Med. Mycol. 39:303-313.
111. De Creus, A., K. Van Beneden, T. Taghon, F. Stolz, V. Debacker, J. Plum, and G. Leclercq. 2000. Langerhans cells that have matured in vivo in the absence of T cells are fully capable of inducing a helper CD4 as well as a cytotoxic CD8 response. J. Immunol. 165:645-653.
112. Deeks, S. G., M. Smith, M. Holodniy, and J. O. Kahn. 1997. HIV-1 protease inhibitors. A review for clinicians. JAMA 277:145-153.
113. Delves, P. J., and I. M. Roitt. 2000. The immune system. First of two parts. N. Engl. J. Med. 343:37-49.
114. Delves, P. J., and I. M. Roitt. 2000. The immune system. Second of two parts. N. Engl. J. Med. 343:108-117.
115. de Repentigny, L. 1992. Setodiagnosis of candidiasis, aspergillosis, and cryptococcosis. Clin. Infect. Dis. 14 (Suppl. 1):S11-S22.
116. de Repentigny, L., F. Aumont, K. Bernard, and P. Belhumeur. 2000. Characterization of binding of Candida albicans to small-intestinal mucin and its role in adherence to mucosal epithelial cells. Infect. Immun. 68:3172-3179.
117. de Repentigny, L., F. Aumont, J. S. Ripeau, M. Fiorillo, D. G. Kay, Z. Hanna, and P. Jolicoeur. 2002. Mucosal candidiasis in transgenic mice expressing human immunodeficiency virus type 1. J. Infect. Dis. 185:1103-1114.
118. Desrosiers, R. C. 1990. The simian immunodeficiency viruses. Annu. Rev. Immunol. 8:557-578.
119. Desrosiers, R. C., and D. J. Ringler. 1989. Use of simian immunodeficiency viruses for AIDS research. Intervirology 30:301-312.
120. + effector T cells in vivo. Clin. Exp. Immunol. 113: 386-393.
121. Detels, R., P. Tarwater, J. P. Phair, J. Margolick, S. A. Riddler, and A. Munoz. 2001. Effectiveness of potent antiretroviral therapies on the incidence of opportunistic infections before and after AIDS diagnosis. AIDS 15:347-355.
122. Diaz-Guerra, T. M., J. V. Martinez-Suarez, F. Laguna, and J. L. Rodriguez-Tudela. 1997. Comparison of four molecular typing methods for evaluating genetic diversity among Candida albicans isolates from human immunodeficiency virus-positive patients with oral candidiasis. J. Clin. Microbiol. 35:856-861.
123. Dickie, P. 2000. Nef modulation of HIV type 1 gene expression and cytopathicity in tissues of HIV transgenic mice. AIDS Res. Hum. Retroviruses 16:777-790.
124. Dickie, P., R. Gazzinelli, and L. J. Chang. 1996. Models of HIV type 1 proviral gene expression in wild-type HIV and MLV/HIV transgenic mice. AIDS Res. Hum. Retroviruses 12:1103-1116.
125. Dickie, P., F. Ramsdell, A. L. Notkins, and S. Venkatesan. 1993. Spontaneous and inducible epidermal hyperplasia in transgenic mice expressing HIV-1 Nef. Virology 197:431-438.
126. Dieleman, J. P., M. Jambroes, I. C. Gyssens, M. C. Sturkenboom, B. H. Stricker, W. M. Mulder, F. de Wolf, G. J. Weverling, J. M. Lange, P. Reiss, and K. Brinkman. 2002. Determinants of recurrent toxicity-driven switches of highly active antiretroviral therapy. The ATHENA cohort. AIDS 16:737-745.
127. Dipaola, C., and I. D. Mandel. 1980. Lactoferrin concentration in human parotid saliva as measured by an enzyme-linked immunosorbent assay (ELISA). J. Dent. Res. 59:1463-1465.
128. Diz, D. P., A. Ocampo, C. Miralles, I. Otero, I. Iglesias, and N. Rayo. 1999. Frequency of oropharyngeal candidiasis in HIV-infected patients on protease inhibitor therapy. Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endod. 87:437-441.
129. Diz, D. P., A. Ocampo, I. Otero, I. Iglesias, and C Martinex. 2001. Changes in oropharyngeal colonization and infection by Candida albicans in human immunodeficiency virus-infected patients. J. Infect. Dis. 183:355-356.
130. Dodd, C. L., D. Greenspan, M. H. Katz, J. L. Westenhouse, D. W. Feigal, and J. S. Greenspan. 1991. Oral candidiasis in HIV infection: pseudomembranous and erythematous candidiasis show similar rates of progression to AIDS. AIDS 5:1339-1343.
131. - plasmacytoid dendritic cells in patients with HIV-1 infection correlates with HIV-1 RNA virus load. Blood 98:2574-2576.
132. Dongari-Bagtzoglou, A., and H. Kashleva. 2003. Granulocyte-macrophage colony-stimulating factor responses of oral epithelial cells to Candida albicans. Oral Microbiol. Immunol. 18:165-170.
133. Dorschner, R. A., V. K. Pestonjamasp, S. Tamakuwala, T. Ohtake, J. Rudisill, V. Nizet, B. Agerberth, G. H. Gudmundsson, and R. L. Gallo. 2001. Cutaneous injury induces the release of cathelicidin anti-microbial peptides active against group A Streptococcus. J. Investig. Dermatol. 117:91-97.
134. a. d'Ostiani, C. F., G. Del Sero, A. Bacci, C. Montagnoli, A. Spreca, A. Mencacci, P. Ricciardi-Castagnoli, and L. Romani. 2000. Dendritic cells discriminate between yeasts and hyphae of the fungus Candida albicans. Implications for initiation of T helper cell immunity in vitro and in vivo. J. Exp. Med. 191:1661-1674.
135. Drobacheff, C., L. Millon, M. Monod, R. Piarroux, E. Robinet, R. Laurent, and D. Meillet. 2001. Increased serum and salivary immunoglobulins against Candida albicans in HIV-infected patients with oral candidiasis. Clin. Chem. Lab. Med. 39:519-526.
136. Dunsche, A., Y. Acil, H. Dommisch, R. Siebert, J. M. Schroder, and S. Jepsen. 2002. The novel human beta-defensin-3 is widely expressed in oral tissues. Eur. J. Oral Sci. 110:121-124.
137. Dunsche, A., Y. Acil, R. Siebert, J. Harder, J. M. Schroder, and S. Jepsen. 2001. Expression profile of human defensins and antimicrobial proteins in oral tissues. J. Oral Pathol. Med. 30:154-158.
138. Dustin, M. L., K. H. Singer, D. T. Tuck, and T. A. Springer. 1988. Adhesion of T Iymphoblasts to epidermal keratinocytes is regulated by interferon gamma and is mediated by intercellular adhesion molecule 1 (ICAM-1). J. Exp. Med. 167:1323-1340.
139. Eales, L. J., J. Farrant, M. Helbert, and A. J. Pinching. 1988. Peripheral blood dendritic cells in persons with AIDS and AIDS related complex: loss of high intensity class II antigen expression and function. Clin. Exp. Immunol 71:423-427.
140. Edgerton, M., S. E. Koshlukova, T. E. Lo, B. G. Chrzan, R. M. Straubinger, and P. A. Raj. 1998. Candidacidal activity of salivary histatins. Identification of a histatin 5-binding protein on Candida albicans. J. Biol. Chem. 273:20438-20447.
141. Edgerton, M., and M. J. Levine. 1992. Characterization of acquired denture pellicle from healthy and stomatitis patients. J. Prosthet. Dent. 68:683-691.
142. Edgerton, M., F. A. Scannapieco, M. S. Reddy, and M. J. Levine. 1993. Human submandibular-sublingual saliva promotes adhesion of Candida albicans to polymethylmethacrylate. Infect. Immun. 61:2644-2652.
143. Eisenberg, S. P., K. K. Hale, P. Heimdal, and R. C. Thompson. 1990. Location of the protease-inhibitory region of secretory leukocyte protease inhibitor. J. Biol. Chem. 265:7976-7981.
144. Elahi, S., G. Pang, R. Clancy, and R. B. Ashman. 2000. Cellular and cytokine correlates of mucosal protection in murine model of oral candidiasis. Infect. Immun. 68:5771-5777.
145. Ellis, M., S. Gupta, S. Galant, S. Hakim, C. VandeVen, C. Toy, and M. S. Cairo, 1988. Impaired neutrophil function in patients with AIDS or AIDS-related complex: a comprehensive evaluation. J. Infect. Dis. 158:1268-1276.
146. Epstein, J. B., L. H. Kimura, T. W. Menard, E. L. Truelove, and N. N. Pearsall. 1982. Effects of specific antibodies on the interaction between the fungus Candida albicans and human oral mucosa. Arch. Oral Biol. 27:469-474.
147. Eroschenko, V. P. 2000. Atlas of histology with functional correlations, di Fiore's, Baltimore, Md.
148. Eversole, L. R., K. T. Miyasaki, and R. E. Christensen. 1993. Keratinocyte expression of calprotectin in oral inflammatory mucosal diseases. J. Oral Pathol. Med. 22:303-307.
149. Eversole, L. R., P. A. Reichart, G. Ficarra, A. Schmidt-Westhausen, P. Romagnoli, and N. Pimpinelli. 1997. Oral keratinocyte immune responses in HIV-associated candidiasis. Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endod. 84:372-380.
150. Fan, Z., X. L. Huang, L. Zheng, C. Wilson, L. Borowski, J. Liebmann, P. Gupta, J. Margolick, and C. Rinaldo. 1997. Cultured blood dendritic cells retain HIV-1 antigen-presenting capacity for memory CTL during progressive HIV-1 infection. J. Immunol. 159:4973-4982.
151. + T lymphocytes in recovery from oropharyngeal candidiasis. Infect. Immun. 70:724-731.
152. Farah, C. S., S. Elahi, G. Pang, T. Gotjamanos, G. J. Seymour, R. L. Clancy, and R. B. Ashman. 2001. T cells augment monocyte and neutrophil function in host resistance against oropharyngeal candidiasis. Infect. Immun. 69:6110-6118.
153. Fauci, A. S., G. Pantaleo, S. Stanley, and D. Weissman. 1996. Immunopathogenic mechanisms of HIV infection. Ann. Intern. Med. 124:654-663.
154. Feigal, D. W., M. H. Katz, D. Greenspan, J. Westenhouse, W. Winkelstein, Jr., W. Lang, M. Samuel, S. P. Buchbinder, N. A. Hessol, A. R. Lifson, et al. 1991. The prevalence of oral lesions in HIV-infected homosexual and bisexual men: three San Francisco epidemiological cohorts. AIDS 5:519-525.
155. Feldman, G. M., and D. S. Finbloom. 1990. Induction and regulation of IL-4 receptor expression on murine macrophage cell lines and bone marrow-derived macrophages by IFN-gamma. J. Immunol. 145:854-859.
156. Ferguson, D. W., and B. D. Volpp. 1994. Cardiovascular complications of AIDS. Heart Dis. Stroke 3:388-394.
157. Fichtenbaum, C. J. 2003. Candidiasis, p. 531-542. In R. Dolin, H. Masur, and M. S. Saag (ed.), AIDS therapy. Churchill Livingstone, Inc., New York, N.Y.
158. Fichtenbaum, C. J., S. Koletar, C. Yiannoutsos, F. Holland, J. Pottage, S. E. Cohn, A. Walawander, P. Frame, J. Feinberg, M. Saag, H. C. Van der, and W. G. Powderly. 2000. Refractory mucosal candidiasis in advanced human immunodeficiency virus infection. Clin. Infect. Dis. 30:749-756.
159. Fidel, P. L., Jr. 2002. Distinct protective host defenses against oral and vaginal candidiasis. Med. Mycol. 40:359-375.
160. Fidel, P. L., Jr., and J. D. Sobel. 1996. Immunopathogenesis of recurrent vulvovaginal candidiasis. Clin. Microbiol. Rev. 9:335-348.
161. Fidel, P. L., Jr., J. A. Vazquez, and J. D. Sobel. 1999. Candida glabrata: review of epidemiology, pathogenesis, and clinical disease with comparison to C. albicans. Clin. Microbiol. Rev. 12:80-96.
162. Fidel, P. L., Jr., N. A. Wolf, and M. A. KuKuruga. 1996. T lymphocytes in the murine vaginal mucosa are phenotypically distinct from those in the periphery. Infect. Immun. 64:3793-3799.
163. Fong, I. W., M. Laurel, and A. Burford-Mason. 1997. Asymptomatic oral carriage of Candida albicans in patients with HIV infection. Clin. Investig. Med. 20:85-93.
164. Formanek, M., B. Knerer, and J. Kornfehl. 1999. Cytokine expression of human oral keratinocytes. J. Otorhinolaryngol. Relat. Spec. 61:103-107.
165. Frank, I., L. Kacani, H. Stoiber, H. Stossel, M. Spruth, F. Steindl, N. Romani, and M. P. Dierich. 1999. Human immunodeficiency virus type 1 derived from cocultures of immature dendritic cells with autologous T cells carries T-cell-specific molecules on its surface and is highly infectious. J. Virol. 73:3449-3454.
166. Frankel, S. S., K. Tenner-Racz, P. Racz, B. M. Wenig, C. H. Hansen, D. Heffner, A. M. Nelson, M. Pope, and R. M. Steinman. 1997. Active replication of HIV-1 at the lymphoepithelial surface of the tonsil. Am. J. Pathol. 151:89-96.
167. Frankel, S. S., B. M. Wenig, A. P. Burke, P. Mannan, L. D. Thompson, S. L. Abbondanzo, A. M. Nelson, M. Pope, and R. M. Steinman. 1996. Replication of HIV-1 in dendritic cell-derived syncytia at the mucosal surface of the adenoid. Science 272:115-117.
168. Frohm, M., B. Agerberth, G. Ahangari, M. Stahle-Backdahl, S. Liden, H. Wigzell, and G. H. Gudmundsson. 1997. The expression of the gene coding for the antibacterial peptide LL-37 is induced in human keratinocytes during inflammatory disorders. J. Biol. Chem. 272:15258-15263.
169. Frohm, N. M., B. Sandstedt, O. Sorensen, G. Weber, N. Borregaard, and M. Stahle-Backdahl. 1999. The human cationic antimicrobial protein (hCAP18), a peptide antibiotic, is widely expressed in human squamous epithelia and colocalizes with interleukin-6. Infect. Immun. 67:2561-2566.
170. Gabrilovich, D. I., A. T. Kozhich, Z. K. Suvorova, V. S. Ivanov, S. A. Moshnikov, L. D. Chikin, O. V. Kolezonkova, and V. V. Pokrovsky. 1991. Influence of HIV antigens on functional activity of neutrophilic granulocytes. Scand. J. Immunol. 33:549-552.
171. Ganser, A. 1988. Abnormalities of hematopoiesis in the acquired immunodeficiency syndrome. Blut 56:49-53.
172. Ganz, T. 2002. Epithelia: not just physical barriers. Proc. Natl. Acad. Sci. USA 99:3357-3358.
173. Gaulton, G. N., J. V. Scobie, and M. Rosenzweig. 1997. HIV-1 and the thymus. AIDS 11:403-414.
174. Ghannoum, M. A. 2000. Potential role of phospholipases in virulence and fungal pathogenesis. Clin. Microbiol. Rev. 13:122-143.
175. Gonwa, T. A., L. J. Picker, H. V. Raff, S. M. Goyert, J. Silver, and J. D. Stobo. 1983. Antigen-presenting capabilities of human monocytes correlates with their expression of HLA-DS, an Ia determinant distinct from HLA-DR. J. Immunol. 130:706-711.
176. Granelli-Piperno, A., E. Delgado, V. Finkel, W. Paxton, and R. M. Steinman. 1998. Immature dendritic cells selectively replicate macrophagetropic (M-tropic) human immunodeficiency virus type 1, while mature cells efficiently transmit both M- and T-tropic virus to T cells. J. Virol. 72:2733-2737.
177. Grassi, F., A. Hosmalin, D. McIlroy, V. Calvez, P. Debre, and B. Autran. 1999. Depletion in blood CD11c-positive dendritic cells from HIV-infected patients. AIDS 13:759-766.
178. Greenberg, M. E., A. J. Iafrate, and J. Skowronski. 1998. The SH3 domain-binding surface and an acidic motif in HIV-1 Nef regulate trafficking of class I MHC complexes. EMBO J. 17:2777-2789.
179. Greenspan, D., E. Komaroff, M. Redford, J. A. Phelan, M. Navazesh, M. E. Alves, H. Kamrath, R. Mulligan, C. E. Barr, and J. S. Greenspan. 2000. Oral mucosal lesions and HIV viral load in the Women's Interagency HIV Study (WIHS). J. Acquir. Immune. Defic. Syndr. 25:44-50.
180. Greenspan, J. S., C. E. Barr, J. J. Sciubba, J. R. Winkler, and The U.S.A. Oral AIDS Collaborative Group. 1992. Oral manifestations of HIV infection. Definitions, diagnostic criteria, and principles of therapy. Oral Surg. Oral Med. Oral Pathol. 73:142-144.
181. Grone, A. 2002. Keratinocytes and cytokines. Vet. Immunol. Immunopathol. 88:1-12.
182. Gruber, A., E. Lukasser-Vogl, M. Borg-von Zepelin, M. P. Dierich, and R. Wurzner. 1998. Human immunodeficiency virus type 1 gp160 and gp41 binding to Candida albicans selectively enhances candidal virulence in vitro. J. Infect. Dis. 177:1057-1063.
183. Grunfeld, C., and K. R. Feingold. 1992. Metabolic disturbances and wasting in the acquired immunodeficiency syndrome. N. Engl. J. Med. 327:329-337.
184. Guthmiller, J. M., K. G. Vargas, R. Srikantha, L. L. Schomberg, P. L. Weistroffer, P. B. McCray, Jr., and B. F. Tack. 2001. Susceptibilities of oral bacteria and yeast to mammalian cathelicidins. Antimicrob. Agents Chemother. 45:3216-3219.
185. Gyurko, C., U. Lendenmann, E. J. Heimerhorst, R. F. Troxler, and F. G. Oppenheim. 2001. Killing of Candida albicans by histatin 5: cellular uptake and energy requirement. Antonie Leeuwenhoek 79:297-309.
186. Ban, Y., M. H. Riesselman, and J. E. Cutler. 2000. Protection against candidiasis by an immunoglobulin G3 (IgGS) monoclonal antibody specific for the same mannotriose as an IgM protective antibody. Infect. Immun. 68:1649-1654.
187. Handschel, J., C. Sunderkotter, F. J. Prott, U. Meyer, B. Kruse-Losler, and U. Joos. 2001. Increase of RM3/1-positive macrophages in radiation-induced oral mucositis. J. Pathol. 193:242-247.
188. Hanna, Z., D. G. Kay, M. Cool, S. Jothy, N. Rebai, and P. Jolicoeur. 1998. Transgenic mice expressing human immunodeficiency virus type 1 in immune cells develop a severe AIDS-like disease. J. Virol. 72:121-132.
189. Hanna, Z., D. G. Kay, N. Rebai, A. Guimond, S. Jothy, and P. Jolicoeur. 1998. Nef harbors a major determinant of pathogenicity for an AIDS-like disease induced by HIV-1 in transgenic mice. Cell 95:163-175.
190. Hanna, Z., N. Rebai, J. Poudrier, and P. Jolicoeur. 2001. Distinct regulatory elements are required for faithful expression of human CD4 in T cells, macrophages, and dendritic cells of transgenic mice. Blood 98:2275-2278.
191. + T cells and in macrophages of transgenic mice. Mol. Cell. Biol. 14:1084-1094.
192. Hanna, Z., X. Weng, D. G. Kay, J. Poudrier, C. Lowell, and P. Jolicoeur. 2001. The pathogenicity of human immunodeficiency virus (HIV) type 1 Nef in CD4C/HIV transgenic mice is abolished by mutation of its SH3-binding domain, and disease development is delayed in the absence of Hck. J. Virol. 75:9378-9392.
193. Harder, J., J. Bartels, E. Christophers, and J. M. Schroder. 2001. Isolation and characterization of human beta-defensin-3, a novel human inducible peptide antibiotic. J. Biol. Chem. 276:5707-5713.
194. Hasseus, B., U. Dahlgren, G. Bergenholtz, and M. Jontell. 1995. Antigen presenting capacity of Langerhans cells from rat oral epithelium. J. Oral Pathol. Med. 24:56-60.
195. Hasseus, B., M. Jontell, G. Bergenholtz, C. Eklund, and U. I. Dahlgren. 1999. Langerhans cells from oral epithelium are more effective in stimulating allogeneic T-cells in vitro than Langerhans cells from skin epithelium. J. Dent. Res. 78:751-758.
196. Heimerhorst, E. J., R. F. Troxler, and F. G. Oppenheim. 2001. The human salivary peptide histatin 5 exerts its antifungal activity through the formation of reactive oxygen species. Proc. Natl. Acad. Sci. USA 98:14637-14642.
197. + T cells is mediated by macrophages through interaction of HIV gp120 with chemokine receptor CXCR4. Nature 395:189-194.
198. Herskowitz, A. 1996. Cardiomyopathy and other symptomatic heart diseases associated with HIV infection. Curr. Opin. Cardiol. 11:325-331.
199. Hill, M. W., J. H. Berg, and I. C. Mackenzie. 1981. Quantitative evaluation of regional differences between epithelia in the adult mouse. Arch. Oral Biol. 26:1063-1067.
200. Hoffman, M. P., and C. G. Haidaris. 1993. Analysis of Candida albicans adhesion to salivary mucin. Infect. Immun. 61:1940-1949.
201. Hoffman, M. P., and C. G. Haidaris. 1994. Identification and characterization of a Candida albicans-binding proteoglycan secreted from rat submandibular salivary glands. Infect. Immun. 62:828-836.
202. Hoover, C. I., M. J. Jantapour, G. Newport, N. Agabian, and S. J. Fisher. 1998. Cloning and regulated expression of the Candida albicans phospholipase B (PLB1) gene. FEMS Microbiol. Lett. 167:163-169.
203. Howcroft, T. K., K. Strebel, M. A. Martin, and D. S. Singer. 1993. Repression of MHC class I gene promoter activity by two-exon Tat of HIV. Science 260:1320-1322.
204. Hube, B. 1996. Candida albicans secreted aspartyl proteinases. Curr. Top. Med. Mycol. 7:55-69.
205. Hube, B. 1998. Possible role of secreted proteinases in Candida albicans infections. Rev. Iberoam. Micol. 15:68-71.
206. Hube, B., M. Monod, D. A. Schofield, A. J. Brown, and N. A. Gow. 1994. Expression of seven members of the gene family encoding secretory aspartyl proteinases in Candida albicans. Mol. Microbiol. 14:87-99.
207. Ibrahim, A. S., F. Mirbod, S. G. Filler, Y. Banno, G. T. Cole, Y. Kitajima, J. E. Edwards, Jr., Y. Nozawa, and M. A. Ghannoum. 1995. Evidence implicating phospholipase as a virulence factor of Candida albicans. Infect. Immun. 63:1993-1998.
208. Itohara, S., A. G. Fair, J. J. Lafaille, M. Bonneville, Y. Takagaki, W. Haas, and S. Tonegawa. 1990. Homing of a gamma delta thymocyte subset with homogeneous T-cell receptors to mucosal epithelia. Nature 343:754-757.
209. Ives, N. J., B. G. Gazzard, and P. J. Easterbrook. 2001. The changing pattern of AIDS-defining illnesses with the introduction of highly active antiretroviral therapy (HAART) in a London clinic. J. Infect. 42:134-139.
210. Jakob, T., J. Ring, and M. C. Udey. 2001. Multistep navigation of Langerhans/dendritic cells in and out of the skin. J. Allergy Clin. Immunol. 108:688-696.
211. Jensen, J., T. Warner, and E. Balish. 1993. Resistance of SCID mice to Candida albicans administered intravenously or colonizing the gut: role of polymorphonuclear leukocytes and macrophages. J. Infect. Dis. 167:912-919.
212. Jensen, J., T. Warner, and E. Balish. 1994. The role of phagocytic cells in resistance to disseminated candidiasis in granulocytopenic mice. J. Infect. Dis. 170:900-905.
213. Jensen, J., T. Warner, C. Johnson, and E. Balish. 1996. Oral immunization of mice against candidiasis. J. Infect. Dis. 174:133-140.
214. Jin, Y., H. K. Yip, Y. H. Samaranayake, J. Y. Yau, and L. P. Samaranayake. 2003. Biofilm-forming ability of Candida albicans is unlikely to contribute to high levels of oral yeast carriage in cases of human immunodeficiency virus infection. J. Clin. Microbiol. 41:2961-2967.
215. Jones-Carson, J., A. Vazquez-Torres, H. C. van der Heyde, T. Warner, R. D. Wagner, and E. Balish. 1995. Gamma delta T cell-induced nitric oxide production enhances resistance to mucosal candidiasis. Nat. Med. 1:552-557.
216. Juntell. M., A. Scheynius, S. C. Ohman, and B. Magnusson. 1986. Expression of Class II transplantation antigens by epithelial cells in oral candidosis, oral lichen planus and gingivitis. J. Oral Pathol. 15:484-488.
217. Joshi, V. V. 1994. Pathology of acquired immunodeficiency syndrome in children. Pediatr. Hematol. Oncol. 11:351-355.
218. Jotwani, R., A. K. Palucka, M. Al Quotub, M. Nouri-Shirazi, J. Kim, D. Bell, J. Banchereau, and C. W. Cutler. 2001. Mature dendritic cells infiltrate the T cell-rich region of oral mucosa in chronic periodontitis: in situ, in vivo, and in vitro studies. J. Immunol. 167:4693-4700.
219. Kahn, J. O., and B. D. Walker. 1998. Acute human immunodeficiency virus type 1 infection. N. Engl. J. Med. 339:33-39.
220. Kanazawa, S., T. Okamoto, and B. M. Peterlin. 2000. Tat competes with CIITA for the binding to P-TEFb and blocks the expression of MHC class II genes in HIV infection. Immunity 12:61-70.
221. Kao, A. S., M. E. Brandt, W. R. Pruitt, L. A. Conn, B. A. Perkins, D. S. Stephens, W. S. Baughman, A. L. Reingold, G. A. Rothrock, M. A. Pfaller, R. W. Pinner, and R. A. Hajjeh. 1999. The epidemiology of candidemia in two United States cities: results of a population-based active surveillance. Clin. Infect. Dis. 29:1164-1170.
222. Kapas, S., A. Bansal, V. Bhargava, R. Maher, D. Malli, E. Hagi-Pavli, and R. P. Allaker. 2001. Adrenomedullin expression in pathogen-challenged oral epithelial cells. Peptides 22:1485-1489.
223. Kapas, S., M. L. Tenchini, and P. M. Farthing. 2001. Regulation of adrenomedullin secretion in cultured human skin and oral keratinocytes. J. Investig. Dermatol. 117:353-359.
224. Kaplan, J. E., D. Hanson, M. S. Dworkin, T. Frederick, J. Bertolli, M. L. Lindegren, S. Holmberg, and J. L. Jones. 2000. Epidemiology of human immunodeficiency virus-associated opportunistic infections in the United States in the era of highly active antiretroviral therapy. Clin. Infect. Dis. 30(Suppl. 1):S5-S14.
225. Katou, F., H. Ohtani, A. Saaristo, H. Nagura, and K. Motegi. 2000. Immunological activation of dermal Langerhans cells in contact with lymphocytes in a model of human inflamed skin. Am. J. Pathol. 156:519-527.
226. Katz, M. H., D. Greenspan, J. Westenhouse, N. A. Hessol, S. P. Buchbinder, A. R. Lifson, S. Shiboski, D. Osmond, A. Moss, M. Samuel, et al. 1992. Progression to AIDS in HIV-infected homosexual and bisexual men with hairy leukoplakia and oral candidiasis. AIDS 6:95-100.
227. Kaul, S., M. C. Fishbein, and R. J. Siegel. 1991. Cardiac manifestations of acquired immune deficiency syndrome: a 1991 update. Am. Heart J. 122:535-544.
228. Kawabe, T., T. Naka, K. Yoshida, T. Tanaka, H. Fujiwara, S. Suematsu, N. Yoshida, T. Kishimoto, and H. Kikutani. 1994. The immune responses in CD40-deficient mice: impaired immunoglobulin class switching and germinal center formation. Immunity 1:167-178.
229. Kay, D. G., P. Yue, Z. Hanna, S. Jothy, E. Tremblay, and P. Jolicoeur. 2002. Cardiac disease in transgenic mice expressing human immunodeficiency virus-1 nef in cells of the immune system. Am. J. Pathol. 161:321-335.
230. Kazazi, F., J. M. Mathijs, P. Foley, and A. L. Cunningham. 1989. Variations in CD4 expression by human monocytes and macrophages and their relationships to infection with the human immunodeficiency virus. J. Gen. Virol. 70:2661-2672.
231. Kirschner, D. E., R. Mehr, and A. S. Perelson. 1998. Role of the thymus in pediatric HIV-1 infection. J. Acquir. Immune Defic. Syndr. Hum. Retrovirol. 18:95-109.
232. Klein, R. S., C. A. Harris, C. B. Small, B. Moll, M. Lesser, and G. H. Friedland. 1984. Oral candidiasis in high-risk patients as the initial manifestation of the acquired immunodeficiency syndrome. N. Engl. J. Med. 311:354-358.
233. Kleinegger, C. L., D. C. Stoeckel, and Z. B. Kurago. 2001. A comparison of salivary calprotectin levels in subjects with and without oral candidiasis. Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endod. 92:62-67.
234. Klotman, P. E., J. Rappaport, P. Ray, J. B. Kopp, R. Franks, L. A. Bruggeman, and A. L. Notkins. 1995. Transgenic models of HIV-1. AIDS 9:313-324.
235. Knight, S. C. 1994. AIDS. A problem of antigen presentation? Curr. Biol. 4:1131-1134.
236. Knight, S. C., and S. Patterson. 1997. Bone marrow-derived dendritic cells, infection with human immunodeficiency virus, and immunopathology. Annu. Rev. Immunol. 15:593-615.
237. Knobel, H., J. Alonso, J. L. Casado, J. Collazos, J. Gonzalez, I. Ruiz, J. M. Kindelan, A. Carmona, J. Juega, and A. Ocampo. 2002. Validation of a simplified medication adherence questionnaire in a large cohort of HIV-infected patients: the GEEMA Study. AIDS 16:605-613.
238. Koelsch, G., J. Tang, J. A. Loy, M. Monod, K. Jackson, S. I. Foundling, and X. Lin. 2000. Enzymic characteristics of secreted aspartic proteases of Candida albicans. Biochim. Biophys. Acta 1480:117-131.
239. Kolokotronis, A., V. Kioses, D. Antoniades, K. Mandraveli, I. Doutsos, and P. Papanayotou. 1994. Immunologic status in patients infected with HIV with oral candidiasis and hairy leukoplakia. Oral Surg. Oral Med. Oral Pathol. 78:41-46.
240. Korting, H. C., M. Schaller, G. Eder, G. Hamm, U. Bohmer, and B. Hube. 1999. Effects of the human immunodeficiency virus (HIV) proteinase inhibitors saquinavir and indinavir on in vitro activities of secreted aspartyl proteinases of Candida albicans isolates from HIV-infected patients. Antimicrob. Agents Chemother. 43:2038-2042.
241. Kuipers, M. E., J. Heegsma, H. I. Bakker, D. K. Meijer, P. J. Swart, E. W. Frijlink, A. C. Eissens, H. G. Vries-Hospers, and J. J. van den Berg. 2002. Design and fungicidal activity of mucoadhesive lactoferrin tablets for the treatment of oropharyngeal candidosis. Drug Deliv. 9:31-38.
242. Kunkl, A., L. Mortara, M. T. Valle, D. Fenoglio, M. P. Terranova, A. M. Megiovanni, A. Alessandrini, P. G. Li, G. Mazzarello, B. Del, V. A. Canessa, D. Bassetti, and F. Manca. 1998. Recognition of antigenic clusters of Candida albicans by T lymphocytes from human immunodeficiency virus-infected persons. J. Infect. Dis. 178:488-496.
243. Kutsch, C. L., D. A. Norris, and W. P. Arend. 1993. Tumor necrosis factor-alpha induces interleukin-1 alpha and interleukin-1 receptor antagonist production by cultured human keratinocytes. J. Investig. Dermatol. 101:79-85.
244. Lacasse, M., C. Fortier, L. Trudel, A. J. Collet, and N. Deslauriers. 1990. Experimental oral candidosis in the mouse: microbiologic and histologic aspects. J. Oral Pathol. Med. 19:136-141.
245. Laible, N. J., and G. R. Germaine. 1985. Bactericidal activity of human lysozyme, muramidase-inactive lysozyme, and cationic polypeptides against Streptococcus sanguis and Streptococcus faecalis: inhibition by chitin oligosaccharides. Infect. Immun. 48:720-728.
246. Lal, K., J. J. Pollock, R. P. Santarpia III, H. M. Heller, H. W. Kaufman, J. Fuhrer, and R. T. Steigbigel. 1992. Pilot study comparing the salivary cationic protein concentrations in healthy adults and AIDS patients: correlation with antifungal activity. J. Acquir. Immune Defic. Syndr. 5:904-914.
247. Lappin, M. B., I. Kimber, and M. Norval. 1996. The role of dendritic cells in cutaneous immunity. Arch. Dermatol. Res. 288:109-121.
248. Lasker, B. A., C. M. Elie, T. J. Lott, A. Espinel-Ingroff, L. Gallagher, R. J. Kuykendall, M. E. Kellum, W. R. Pruitt, D. W. Warnock, D. Rimland, M. M. McNeil, and E. Reiss. 2001. Molecular epidemiology of Candida albicans strains isolated from the oropharynx of HIV-positive patients at successive clinic visits. Med. Mycol. 39:341-352.
249. Launay, O., O. Lortholary, C. Bouges-Michel, B. Jarrousse, M. Bentata, and L. Guillevin. 1998. Candidemia: a nosocomial complication in adults with late-stage AIDS. Clin. Infect. Dis. 26:1134-1141.
250. Le Gall, S., L. Erdtmann, S. Benichou, C. Berlioz-Torrent, L. Liu, R. Benarous, J. M. Heard, and O. Schwartz. 1998. Nef interacts with the mu subunit of clathrin adaptor complexes and reveals a cryptic sorting signal in MHC I molecules. Immunity 8:483-495.
251. Leidich, S. D., A. S. Ibrahim, Y. Fu, A. Koul, C. Jessup, J. Vitullo, W. Fonzi, F. Mirbod, S. Nakashima, Y. Nozawa, and M. A. Ghannoum. 1998. Cloning and disruption of caPLB1, a phospholipase B gene involved in the pathogenicity of Candida albicans. J. Biol. Chem. 273:26078-26086.
252. Leigh, J. E., M. Barousse, R. K. Swoboda, T. Myers, S. Hager, N. A. Wolf, J. L. Cutright, J. Thompson, J. D. Sobel, and P. L. Fidel, Jr. 2001. Candida-specific systemic cell-mediated immune reactivities in human immunodeficiency virus-positive persons with mucosal candidiasis. J. Infect. Dis. 183:277-285.
253. Leigh, J. E., C. Steele, F. Wormley, and P. L. Fidel, Jr. 2002. Salivary cytokine profiles in the immunocompetent individual with Candida-associated denture stomatitis. Oral Microbiol. Immunol. 17:311-314.
254. Leigh, J. E., C. Steele, F. L. Wormley, Jr., W. Luo, R. A. Clark, W. Gallaher, and P. L. Fidel, Jr. 1998. Th1/Th2 cytokine expression in saliva of HIV-positive and HIV-negative individuals: a pilot study in HIV-positive individuals with oropharyngeal candidiasis. J. Acquir. Immune Defic. Syndr. Hum. Retrovirol. 1:373-380.
255. Lenander-Lumikari, M., and I. Johansson. 1995. Effect of saliva composition on growth of Candida albicans and Torulopsis glabrata. Oral Microbiol. Immunol. 10:233-240.
256. Leonard, J. M., J. W. Abramczuk, D. S. Pezen, R. Rutledge, J. H. Belcher, F. Hakim, G. Shearer, L. Lamperth, W. Travis, T. Fredrickson, et al. 1988. Development of disease and virus recovery in transgenic mice containing HIV proviral DNA. Science 242:1665-1670.
257. Levine, A. M. 2002. Evaluation and management of HIV-infected women. Ann. Intern. Med. 136:228-242.
258. Levitz, S. M., H. L. Mathews, and J. W. Murphy. 1995. Direct antimicrobial activity of T cells. Immunol. Today 16:387-391.
259. Li, J., P. M. Farthing, G. W. Ireland, and M. H. Thornhill. 1996. IL-1 alpha and IL-6 production by oral and skin keratinocytes: similarities and differences in response to cytokine treatment in vitro. J. Oral Pathol. Med. 25:157-162.
260. Lin, A. L., D. A. Johnson, T. F. Patterson, Y. Wu, D. L. Lu, Q. Shi, and C. K. Yeh. 2001. Salivary anticandidal activity and saliva composition in an HIV-infected cohort. Oral Microbiol. Immunol. 16:270-278.
261. Lindemann, D., R. Wilhelm, P. Renard, A. Althage, R. Zinkernagel, and J. Mous. 1994. Severe immunodeficiency associated with a human immunodeficiency virus 1 NEF/3′-long terminal repeat transgene. J. Exp. Med. 179:797-807.
262. Lipshultz, S. E. (ed.). 1998. Cardiology in AIDS. Chapman & Hall, New York, N.Y.
263. Liu, A. Y., D. Destoumieux, A. V. Wong, C. H. Park, E. V. Valore, L. Liu, and T. Ganz. 2002. Human beta-defensin-2 production in keratinocytes is regulated by interleukin-1, bacteria, and the state of differentiation. J. Investig. Dermatol. 118:275-281.
264. Lombardi, T., C. Hauser, and E. Budtz-Jorgensen. 1993. Langerhans cells: structure, function and role in oral pathological conditions. J. Oral Pathol. Med. 22:193-202.
265. Lopez-Dupla, M., S. P. Mora, G. Pintado, V, O. E. Valencia, P. L. Uriol, M. A. Khamashta, and A. G. Aguado. 1992. Clinical, endoscopic, immunologic, and therapeutic aspects of oropharyngeal and esophageal candidiasis in HIV-infected patients: a survey of 114 cases. Am. J. Gastroenterol. 87:1771-1776.
266. + dendritic cells with reduced CD80 and CD86 expression in lymphoid tissue during acute HIV-1 infection. AIDS 16:683-692.
267. + T-cells by HIV-infected monocytes is related to down-modulation of CD4 expression on helper T-cells: possible involvement of HIV-induced cellular factors. FEBS Lett. 398:1-6.
268. Lu, X. S., J. F. Delfraissy, L. Grangeot-Keros, M. T. Rannou, and J. Pillot. 1994. Rapid and constant detection of HIV antibody response in saliva of HIV-infected patients; selective distribution of anti-HIV activity in the IgG isotype. Res. Virol. 145:369-377.
269. Lundqvist, C., V. Baranov, S. Teglund, S. Hammarstrom, and M. L. Hammarstrom. 1994. Cytokine profile and ultrastructure of intraepithelial gamma delta T cells in chronically inflamed human gingiva suggest a cytotoxic effector function. J. Immunol. 153:2302-2312.
270. Lundqvist, C., and M. L. Hammarstrom. 1993. T-cell receptor gamma delta-expressing intraepithelial lymphocytes are present in normal and chronically inflamed human gingiva. Immunology 79:38-45.
271. Lupetti, A., G. Guzzi, A. Paladini, K. Swart, M. Campa, and S. Senesi. 1995. Molecular typing of Candida albicans in oral candidiasis: karyotype epidemiology with human immunodeficiency virus-seropositive patients in comparison with that with healthy carriers. J. Clin. Microbiol. 33:1238-1242.
272. Macallan, D. C. 1999. Wasting in HIV infection and AIDS. J. Nutr. 129:238S-242S.
273. Macatonia, S. E., R. Lau, S. Patterson, A. J. Pinching, and S. C. Knight. 1990. Dendritic cell infection, depletion and dysfunction in HIV-infected individuals. Immunology 71:38-45.
274. MacDonald, A. S., and E. J. Pearce. 2002. Cutting edge: polarized Th cell response induction by transferred antigen-pulsed dendritic cells is dependent on IL-4 or IL-12 production by recipient cells. J. Immunol. 168:3127-3130.
275. Maenza, J. R., W. G. Merz, M. J. Romagnoli, J. C. Keruly, R. D. Moore, and J. E. Gallant. 1997. Infection due to fluconazole-resistant Candida in patients with AIDS: prevalence and microbiology. Clin. Infect. Dis. 24:28-34.
276. Mandel, I. D., C. E. Barr, and L. Turgeon. 1992. Longitudinal study of parotid saliva in HIV-1 infection. J. Oral Pathol. Med. 21:209-213.
277. Marcotte, H., and M. C. Lavoie. 1998. Oral microbial ecology and the role of salivary immunoglobulin A. Microbiol. Mol. Biol. Rev. 62:71-109.
278. Marder, M. Z., C. E. Barr, and I. D. Mandel. 1985. Cytomegalovirus presence and salivary composition in acquired immunodeficiency syndrome. Oral Surg. Oral Med. Oral Pathol. 60:372-376.
279. + cell count and viral load in an Italian study population. J. Oral Pathol. Med. 28:173-177.
280. Marina, N. M., P. M. Flynn, G. K. Rivera, and W. T. Hughes. 1991. Candida tropicalis and Candida albicans fungemia in children with leukemia. Cancer 68:594-599.
281. Marquis, G., S. Montplaisir, S. Garzon. H. Strykowski, and P. Auger. 1982. Fungitoxicity of muramidase. Ultrastractural damage to Candida albicans. Lab. Investig. 46:627-636.
282. Martins, M. D., M. Lozano-Chiu, and J. H. Rex. 1998. Declining rates of oropharyngeal candidiasis and carriage of Candida albicans associated with trends toward reduced rates of carriage of fluconazole-resistant C. albicans in human immunodeficiency virus-infected patients. Clin. Infect. Dis. 27:1291-1294.
283. Mathews, M., H. P. Jia, J. M. Guthmiller, G. Losh, S. Graham, G. K. Johnson, B. F. Tack, and P. B. McCray, Jr. 1999. Production of beta-defensin antimicrobial peptides by the oral mucosa and salivary glands. Infect. Immun. 67:2740-2745.
284. Matsuura, K., F. Otsuka, and H. Fujisawa. 1998. Effects of interferons on tumour necrosis factor alpha production from human keratinocytes. Cytokine 10:500-505.
285. Mattsson, T., K. G. Sundqvist, A. Heimdahl, G. Dahllof, P. Ljungman, and O. Ringden. 1992. A comparative immunological analysis of the oral mucosa in chronic graft-versus-host disease and oral lichen planus. Arch. Oral Biol. 37:539-547.
286. Mazurier, J., and G. Spik. 1980. Comparative study of the iron-binding properties of human transferrins. I. Complete and sequential iron saturation and desaturation of the lactotransferrin. Biochim. Biophys. Acta 629:399-408.
287. McCarthy, G. M. 1992. Host factors associated with HIV-related oral candidiasis. A review. Oral Surg. Oral Med. Oral Pathol. 73:181-186.
288. + patients. AIDS Res. Hum. Retroviruses 14:505-513.
289. McNeely, T. B., M. Dealy, D. J. Dripps, J. M. Orenstein, S. P. Eisenberg, and S. M. Wahl. 1995. Secretory leukocyte protease inhibitor: a human saliva protein exhibiting anti-human immunodeficiency virus 1 activity in vitro. J. Clin. Investig. 96:456-464.
290. McSherry, G. D. 1996. Human immunodeficiency-virus-related pulmonary infections in children. Semin. Respir. Infect. 11:173-183.
291. Medzhitov, R., and C. Janeway, Jr. 2000. Innate immunity. N. Engl. J. Med. 343:338-344.
292. Meiller, T. F., M. A. Jabra-Rizk, A. Baqui, J. I. Kelley, V. I. Meeks, W. G. Merz, and W. A. Falkler. 1999. Oral Candida dubliniensis as a clinically important species in HIV-seropositive patients in the United States. Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endod. 88:573-580.
293. + T helper type 1 cell responses to Candida albicans. J. Exp. Med. 187:307-317.
294. Mezzaroma, I., M. Carlesimo, E. Pinter, C. Alario, G. Sacco, D. S. Muratori, M. L. Bernardi, R. Paganelli, and F. Aiuti. 1999. Long-term evaluation of T-cell subsets and T-cell function after HAART in advanced stage HIV-1 disease. AIDS 13:1187-1193.
295. Michaels, A. D., R. J. Lederman, J. S. MacGregor, and M. D. Cheitlin. 1997. Cardiovascular involvement in AIDS. Curr. Probl. Cardiol. 22:109-148.
296. Mohamed, A. M. 1975. Ultrastructural aspects of chronic oral candidosis. J. Oral Pathol. 4:180-194.
297. Monod, M., B. Hube, D. Hess, and D. Sanglard. 1998. Differential regulation of SAP8 and SAP9, which encode two new members of the secreted aspartic proteinase family in Candida albicans. Microbiology 144:2731-2737.
298. Morace, G., E. Tamburrini, S. Manzara, A. Antinori, G. Maiuro, and G. Dettori. 1990. Epidemiological and clinical aspects of mycoses in patients with AIDS-related pathologies. Eur. J. Epidemiol. 6:398-403.
299. Moses, A., J. Nelson, and G. C. Bagby, Jr. 1998. The influence of human immunodeficiency virus-1 on hematopoiesis. Blood 91:1479-1495.
300. Muller, F., S. S. Froland, P. Brandtzaeg, and M. K. Fagerhol. 1993. Oral candidiasis is associated with low levels of parotid calprotectin in individuals with infection due to human immunodeficiency virus. Clin. Infect. Dis. 16:301-302.
301. Muller, F., S. S. Froland, M. Hvatum, J. Radl, and P. Brandtzaeg. 1991. Both IgA subclasses are reduced in parotid saliva from patients with AIDS. Clin. Exp. Immunol. 83:203-209.
302. Muller, F., M. Holberg-Petersen, H. Rollag, M. Degre, P. Brandtzaeg, and S. S. Froland. 1992. Nonspecific oral immunity in individuals with HIV infection. J. Acquir. Immune. Defic. Syndr. 5:46-51.
303. Muller, F. M., M. Kasai, A. Francesconi, B. Brillante, M. Roden, J. Peter, S. J. Chanock, and T. J. Walsh. 1999. Transmission of an azole-resistant isogenic strain of Candida albicans among human immunodeficiency virus-infected family members with oropharyngeal candidiasis. J. Clin. Microbiol. 37:3405-3408.
304. Muller, H., S. Weier, G. Kojouharoff, M. Grez, S. Berger, R. Kappus, P. M. Shah, H. J. Stutte, and H. L. Schmidts. 1993. Distribution and infection of Langerhans cells in the skin of HIV-infected healthy subjects and AIDS patients. Res. Virol. 144:59-67.
305. Munk, M. E., A. J. Gatrill, and S. H. Kaufmann. 1990. Target cell lysis and IL-2 secretion by gamma/delta T lymphocytes after activation with bacteria. J. Immunol. 145:2434-2439.
306. Munro, C. A., and B. Hube. 2002. Anti-fungal therapy at the HAART of viral therapy. Trends Microbiol. 10:173-177.
307. Myers, T. A., J. E. Leigh, A. R. Arribas, S. Hager, R. Clark, E. Lilly, and P. L. Fidel, Jr. 2003. Immunohistochemical evaluation of T cells in oral lesions from human immunodeficiency virus-positive persons with oropharyngeal candidiasis. Infect. Immun. 71:956-963.
308. Myint, M., S. Steinsvoll, Z. N. Yuan, B. Johne, K. Helgeland, and K. Schenck. 2002. Highly increased numbers of leukocytes in inflamed gingiva from patients with HIV infection. AIDS 16:235-243.
309. Naglik, J. R., G. Newport, T. C. White, L. L. Fernandes-Naglik, J. S. Greenspan, D. Greenspan, S. P. Sweet, S. J. Challacombe, and N. Agabian. 1999. In vivo analysis of secreted aspartyl proteinase expression in human oral candidiasis. Infect. Immun. 67:2482-2490.
310. Nakanishi, K., T. Yoshimoto, H. Tsutsui, and H. Okamura. 2001. Interleukin-18 regulates both Th1 and Th2 responses. Annu. Rev. Immunol. 19:423-474.
311. Narayanan, R., W. A. Joyce, and R. A. Greenfield. 1991. Gastrointestinal candidiasis in a murine model of severe combined immunodeficiency syndrome. Infect. Immun. 59:2116-2119.
312. Newman, S. L., and A. Holly. 2001. Candida albicans is phagocytosed, killed, and processed for antigen presentation by human dendritic cells. Infect. Immun. 69:6813-6822.
313. Nielsen, H., K. D. Bentsen, L. Hojtved, E. H. Willemoes, F. Scheutz, M. Schiodt, K. Stoltze, and J. J. Pindborg. 1994. Oral candidiasis and immune status of HIV-infected patients. J. Oral Pathol. Med. 23:140-143.
314. Nielsen, H., A. Kharazmi, and V. Faber. 1986. Blood monocyte and neutrophil functions in the acquired immune deficiency syndrome. Scand. J. Immunol. 24:291-296.
315. Nikawa, H., L. P. Samaranayake, J. Tenovuo, K. M. Pang, and T. Hamada. 1993. The fungicidal effect of human lactoferrin on Candida albicans and Candida krusei. Arch. Oral Biol. 38:1057-1063.
316. Nose, Y., K. Komori, H. Inouye, K. Nomura, M. Yamamura, and K. Tsuji. 1981. Role of macrophages in T lymphocyte response to Candida allergen in man with special reference to HLA-D and DR. Clin. Exp. Immunol. 45:152-157.
317. Nottet, H. S., L. de Graaf, N. M. de Vos, L. J. Bakker, J. A. van Strijp, M. R. Visser, and J. Verhoef. 1993. Phagocytic function of monocyte-derived macrophages is not affected by human immunodeficiency virus type 1 infection. J. Infect. Dis. 168:84-91.
318. O'Brien, W. A. 2000. Resistance against reverse transcriptase inhibitors. Clin. Infect. Dis. 30(Suppl. 2):S185-S192.
319. O'Connell, B. C., T. Xu, T. J. Walsh, T. Sein, A. Mastrangeli, R. G. Crystal, F. G. Oppenheim, and B. J. Baum. 1996. Transfer of a gene encoding the anticandidal protein histatin 3 to salivary glands. Hum. Gene Ther. 7:2255-2261.
320. Odden, K., K. Schenck, and B. Hurlen. 1995. High numbers of T cells in gingiva from patients with human immunodeficiency virus (HIV) infection. J. Oral Pathol. Med. 24:413-419.
321. Odds, F. C. 1988. Candida and candidasis: a review and bibliography.
322. Ohman, S. C., M. Jontell, and R. Jonsson. 1989. Phenotypic characterization of mononuclear cells and class II antigen expression in angular cheilitis infected by Candida albicans or Staphylococcus aureus. Scand. J Dent. Res. 97:178-185.
323. Ollert, M. W., C. Wende, M. Gorlich, C. G. McMullan-Vogel, M. Borg-von Zepelin, C. W. Vogel, and H. C. Korting. 1995. Increased expression of Candida albicans secretory proteinase, a putative virulence factor, in isolates from human immunodeficiency virus-positive patients. J. Clin. Microbiol. 33:2543-2549.
324. + (myeloid) dendritic cell numbers in primary HIV-1 infection. Blood 98:3016-3021.
325. Pakker, N. G., M. T. Roos, R. van Leeuwen, M. D. de Jong, M. Koot, P. Reiss, J. M. Lange, F. Miedema, S. A. Danner, and P. T. Schellekens. 1997. Patterns of T-cell repopulation, virus load reduction, and restoration of T-cell function in HIV-infected persons during therapy with different antiretroviral agents. J. Acquir. Immune Defic. Syndr. Hum. Retrovirol. 16:318-326.
326. Palella, F. J., Jr., K. M. Delaney, A. C. Moorman, M. O. Loveless, J. Fuhrer, G. A. Satten, D. J. Aschman, S. D. Holmberg, and the HIV Outpatient Study Investigators. 1998. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. N. Engl. J. Med. 338:853-860.
327. Pantaleo, G., and A. S. Fauci. 1995. New concepts in the immunopathogenesis of HIV infection. Annu. Rev. Immunol. 13:487-512.
328. Pantaleo, G., C. Graziosi, J. F. Demarest, L. Butini, M. Montronl, C. H. Fox, J. M. Orenstein, D. P. Kotler, and A. S. Fauci. 1993. HIV infection is active and progressive in lymphoid tissue during the clinically latent stage of disease. Nature 362:355-358.
329. Pantaleo, G., C. Graziosi, and A. S. Fauci. 1993. The role of lymphoid organs in the immunopathogenesis of HIV infection. AIDS 7(Suppl. 1): S19-S23.
330. Patterson, S., N. R. English, H. Longhurst, P. Balfe, M. Helbert, A. J. Pinching, and S. C. Knight. 1998. Analysis of human immunodeficiency virus type 1 (HIV-1) variants and levels of infection in dendritic and T cells from symptomatic HIV-1-infected patients. J. Gen. Virol. 79:247-257.
331. Patton, L. L. 2000. Sensitivity, specificity, and positive predictive value of oral opportunistic infections in adults with HIV/AIDS as markers of immune suppression and viral burden. Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endod. 90:182-188.
332. Pena, J. M., M. A. Martinez-Lopez, F. Arnalich, F. J. Barbado, and J. J. Vazquez. 1991. Esophageal candidiasis associated with acute infection due to human immunodeficiency virus: case report and review. Rev. Infect. Dis. 13:872-875.
333. Pepin, L. F., T. Roger, J. Morisset, and M. Seman. 1993. Preferential V delta 1 expression among TcR gamma/delta-bearing T cells in human oral epithelium. Scand. J. Immunol, 37:289-294.
334. Perea, S., J. L. Lopez-Ribot, W. R. Kirkpatrick, R. K. McAtee, R. A. Santillan, M. Martinez, D. Calabrese, D. Sanglard, and T. F. Patterson. 2001. Prevalence of molecular mechanisms of resistance to azole antifungal agents in Candida albicans strains displaying high-level fluconazole resistance isolated from human immunodeficiency virus-infected patients. Antimicrob. Agents Chemother. 45:2676-2684.
335. Petrosillo, N., P. Viale, E. Nicastri, C. Arici, E. Bombana, A. Casella, F. Cristini, M. De Gennaro, F. Dodi, A. Gabbuti, G. Gattuso, L. Irato, P. Maggi, F. Pallavicini, A. Pan, M. Pantaleoni, and G. Ippolito. 2002. Nosocomial bloodstream infections among human immunodeficiency virus-infected patients: incidence and risk factors. Clin. Infect. Dis. 34:677-685.
336. Fieri, L., L. Domenici, and P. Romagnoli. 2001. Langerhans cells differentiation: a three-act play. Ital. J. Anat. Embryol. 106:47-69.
337. Pietrella, D., T. R. Kozel, C. Monari, F. Bistoni, and A. Vecchiarelli. 2001. Interleukin-12 counterbalances the deleterious effect of human immunodeficiency virus type 1 envelope glycoprotein gp120 on the immune response to Cryptococcus neoformans, J. Infect. Dis. 183:51-58.
338. Pileri, S, M. T. Rivano, E. Raise, G. Gualandi, M. Gobbi, M. Martuzzi, F. M. Gritti, J. Gerdes, and H. Stein. 1986. The value of lymph node biopsy in patients with the acquired immunodeficiency syndrome (AIDS) and the AIDS-related complex (ARC): a morphological and immunohistochemical study of 90 cases. Histopathology 10:1107-1129.
339. Pillay, D., S. Taylor, and D. D. Richman. 2000. Incidence and impact of resistance against approved antiretroviral drugs. Rev. Med. Virol. 10:231-253.
340. + subjects. J. Investig. Dermatol. 97:537-542.
341. Polyak, S., H. Chen, D. Hirsch, I. George, R. Hershberg, and K. Sperber. 1997. Impaired class II expression and antigen uptake in monocytic cells after HIV-1 infection. J. Immunol. 159:2177-2188.
342. Pope, M. 1999. Mucosal dendritic cells and immunodeficiency viruses. J. Infect. Dis. 179(Suppl. 3):S427-S430.
343. Pope, M., D. Elmore, D. Ho, and P. Marx. 1997. Dendritic cell-T cell mixtures, isolated from the skin and mucosae of macaques, support the replication of SIV. AIDS Res. Hum. Retroviruses 13:819-827.
344. Poudrier, J., X. Weng, D. G. Kay, G. Pare, E. L. Calvo, Z. Hanna, M. H. Kosco-Vilbois, and P. Jolicoeur. 2001. The AIDS disease of CD4C/HIV transgenic mice shows impaired germinal centers and autoantibodies and develops in the absence of IFN-gamma and IL-6. Immunity 15:173-185.
345. a. Poudrier, J., X. Weng, D. G. Kay, Z. Hanna, and P. Jolicoeur. 2003. The AIDS-like disease of CD4C/human immunodeficiency virus transgenic mice is associated with accumulation of immature CD11b Hi dendritic cells. J. Virol. 77:11733-11744.
346. Powderly, W. G. 1992. Mucosal candidiasis caused by non-albicans species of Candida in HIV-positive patients. AIDS 6:604-605.
347. Powderly, W. G., K. Robinson, and E. J. Keath. 1993. Molecular epidemiology of recurrent oral candidiasis in human immunodeficiency virus-positive patients: evidence for two patterns of recurrence. J. Infect. Dis. 168:463-466.
348. Pugliese, A., D. Torre, F. M. Baccino, G. Di Perri, C. Cantamessa, L. Gerbaudo, A. Saini, and V. Vidotto. 2000. Candida albicans and HIV-1 infection. Cell Biochem. Funct. 18:235-241.
349. Quinti, I., C. Palma, E. C. Guerra, M. J. Gomez, I. Mezzaroma, F. Aiuti, and A. Cassone. 1991. Proliferative and cytotoxic responses to mannoproteins of Candida albicans by peripheral blood lymphocytes of HIV-infected subjects. Clin. Exp. Immunol. 85:485-492.
350. Qureshi, M. N., C. E. Barr, I. Hewlitt, R. Boorstein, F. Kong, O. Bagasra, L. E. Bobroski, and B. Joshi. 1997. Detection of HIV in oral mucosal cells. Oral Dis. 3(Suppl. 1):S73-S78.
351. Qureshi, M. N., C. E. Barr, T. Seshamma, J. Reidy, R. J. Pomerantz, and O. Bagasra. 1995. Infection of oral mucosal cells by human immunodeficiency virus type 1 in seropositive persons. J. Infect. Dis. 171:190-193.
352. Rabeneck, L., and L. Laine. 1994. Esophageal candidiasis in patients infected with the human immunodeficiency virus. A decision analysis to assess cost-effectiveness of alternative management strategies. Arch. Intern. Med. 154:2705-2710.
353. Raeste, A. M., and H. Tuompo. 1976. Lysozyme activity and flow rate of mixed saliva in children, adolescents and adults. Scand. J. Dent. Res. 84:418-422.
354. Raffaniello, R. D., and M. Roy. 1990. Immunohistological analysis of the immune cells in the normal oral mucosa of aging mice. Gerodontology 9:51-57.
355. Rappaport, J., J. B. Kopp, and P. E. Klotman. 1994. Host virus interactions and the molecular regulation of HIV-1: role in the pathogenesis of HIV-associated nephropathy. Kidney Int. 46:16-27.
356. Re, M. C., G. Furlini, G. Zauli, and M. La Placa. 1994. Human immunodeficiency virus type 1 (HIV-1) and human hematopoietic progenitor cells. Arch. Virol. 137:1-23.
357. Redding, S. W., M. A. Pfaller, S. A. Messer, J. A. Smith, J. Prows, L. L. Bradley, A. W. Fothergill, and M. G. Rlnaldi. 1997. Variations in fluconazole susceptibility and DNA subtyping of multiple Candida albicans colonies from patients with AIDS and oral candidiasis suffering one or more episodes of infection. J. Clin. Microbiol. 35:1761-1765.
358. Reef, S. E. and K. H. Mayer. 1995. Opportunistic candidal infections in patients infected with human immunodeficiency virus: prevention issues and priorities. Clin. Infect. Dis. 21(Suppl, 1):S99-S102.
359. Reibel, J., E. Dabelsteen, B. Kenrad, and K. Buschard. 1985. Pattern of distribution of T lymphocytes, Langerhans cells and HLA-DR bearing cells in normal human oral mucosa. Scand. J. Dent. Res. 93:513-521.
360. Reichart, P. A., H. P. Philipsen, A. Schmidt-Westhausen, and L. P. Samaranayake. 1995. Pseudomembranous oral candidiasis in HIV infection: ultrastructural findings. J. Oral Pathol. Med. 24:276-281.
361. Reichart, P. A., L. P. Samaranayake, and H. P. Philipsen. 2000. Pathology and clinical correlates in oral candidiasts and its variants: a review. Oral Dis. 6:85-91.
362. Reichart, P. A., A. Schmidt-Westhausen, L. P. Samaranayake, and H. P. Philipsen. 1994. Candida-associated palatal papillary hyperplasia in HIV infection. J. Oral Pathol. Med. 23:403-405.
363. Reichart, P. A., D. Weigel, A. Schmidt-Westhausen, and H. D. Pohle. 1997. Exfoliative cheilitis (EC) in AIDS: association with Candida infection. J. Oral Pathol. Med. 26:290-293.
364. Rhodus, N. L., C. Bloomquist, W. Liljemark, and J. Bereuter. 1997. Prevalence, density, and manifestations of oral Candida albicans in patients with Sjogren's syndrome. J. Otolaryngol. 26:300-305.
365. Richman, D. D. 2001. HIV chemotherapy. Nature 410:995-1001.
366. Ripeau, J. S., M. Fiorillo, F. Aumont, P. Belhumeur, and L. de Repentigny. 2002. Evidence for differential expression of Candida albicans virulence genes during oral infection in intact and human immunodeficiency virus type 1-transgenic mice. J. Infect. Dis. 185:1094-1102.
367. Rittman, B. R., M. W. Hill, G. A. Rittman, and I. C. Mackenzie. 1987. Age-associated changes in Langerhans cells of murine oral epithelium and epidermis. Arch. Oral Biol. 32:885-889.
368. Rittman, B. R., I. C. Mackenzie, and G. A. Rittman. 1989. Replacement of Langerhans cells in murine palate. J. Oral Pathol. Med. 18:279-281.
369. Robinson, P. G., S. J. Challacombe, A. Sheiham, and J. M. Zakrzewska. 1997. Is erythematous candidiasis associated with advanced HIV disease? Oral Dis. 3(Suppl 1):S116-S118.
370. Romagnoli, P., N. Pimpinelli, M. Mori, P. A. Reichart, L. R. Eversole, and G. Ficarra. 1997. Immunocompetent cells in oral candidiasis of HIV-infected patients: an immunohistochemical and electron microscopical study. Oral Dis. 3:99-105.
371. Rosini, S., S. Caltagirone, G. Tallini, G. Lattanzio, R. Demopoulos, M. Piantelli, and P. Musiani. 1996. Depletion of stromal and intraepithelial antigen-presenting cells in cervical neoplasia in human immunodeficiency virus infection. Hum. Pathol. 27:834-838.
372. Ross, H., L. J. Romrell, and G. I. Kaye. 1995. Histology: a text and atlas. The Williams & Wilkins Co., Baltimore, Md.
373. Ross, K. F., and M. C. Herzberg. 2001. Calprotectin expression by gingival epithelial cells. Infect. Immun. 69:3248-3254.
374. Rudney, J. D., K. C. Kajander, and Q. T. Smith. 1985. Correlations between human salivary levels of lysozyme, lactoferrin, salivary peroxidaseand secretory immunoglobulin A with different stimulatory states and over time. Arch. Oral Biol. 30:765-771.
375. Runeman, B., J. Faergemann, and O. Larko. 2000. Experimental Candida albicans lesions in healthy humans: dependence on skin pH. Acta Dermatol. Venereol. 80:421-424.
376. Samaranayake, L. P. 1990. Host factors and oral candidosis, p. 66-103. In L. Y. Samaranayake and T. W. MacFarlane (ed.), Oral candidosis. Butterworth & Co. Ltd., London, United Kingdom.
377. Samaranayake, L. P. 1992. Oral mycoses in HIV infection. Oral Surg. Oral Med. Oral Pathol. 73:171-180.
378. Samaranayake, L. P., and P. Holmstrup. 1989. Oral candidiasis and human immunodeficiency virus infection. J. Oral Pathol. Med. 18:554-564.
379. Samaranayake, L. P., A. Hughes, D. A. Weetman, and T. W. MacFarlane. 1986. Growth and acid production of Candida species in human saliva supplemented with glucose. J. Oral Pathol. 15:251-254.
380. Samaranayake, L. P., and T. W. MacFarlane. 1982. Factors affecting the in-vitro adherence of the fungal oral pathogen Candida albicans to epithelial cells of human origin. Arch. Oral Biol. 27:869-873.
381. Samaranayake, Y. H., and L. P. Samaranayake. 2001. Experimental oral candidiasis in animal models. Clin. Microbiol. Rev. 14:398-429.
382. Samaranayake, Y. H., L. P. Samaranayake, E. H. Pow, V. T. Beena, and K. W. Yeung. 2001. Antifungal effects of lysozyme and lactoferrin against genetically similar, sequential Candida albicans isolates from a human immunodeficiency virus-infected southern Chinese cohort. J. Clin. Microbiol. 39:3296-3302.
383. Sangeorxan, J. A., S. F. Bradley, X. He, L. T. Zarins, G. L. Ridenour, R. N. Tiballi, and C. A. Kauffman. 1994. Epidemiology of oral candidiasis in HIV-infected patients: colonization, infection, treatment, and emergence of fluconazole resistance. Am. J. Med. 97:339-346.
384. + T cell homeostasis and in vitro HIV-1 susceptibility in transgenic mice expressing T cell line-tropic HIV-1 receptors. J. Exp. Med. 187:1439-1449.
385. Sawada, S., and D. R. Littman. 1991. Identification and characterization of a T-cell-specific enhancer adjacent to the murine CD4 gene. Mol. Cell. Biol. 11:5506-5515.
386. Schaller, M., R. Mailhammer, and H. C. Korting. 2002. Cytokine expression induced by Candida albicans in a model of cutaneous candidosis based on reconstituted human epidermis. J. Med. Microbiol. 51:672-676.
387. Schaller, M., W. Schafer, H. C. Korting, and B. Hube. 1998. Differential expression of secreted aspartyl proteinases in a model of human oral candidosis and in patient samples from the oral cavity. Mol. Microbiol. 29:605-615.
388. Schoenberger, S. P., R. E. Toes, E. I. van der Voort, R. Offringa, and C. J. Melief. 1998. T-cell help for cytotoxic T lymphocytes is mediated by CD40-CD40L interactions. Nature 393:480-483.
389. Schorling, S. R., H. C. Kortinga, M. Froschb, and F. A. Muhlschlegel. 2000. The role of Candida dubliniensis in oral candidiasis in human immunodeficiency virus-infected individuals. Crit Rev. Microbiol. 26:59-68.
390. Schroder, J. M. and J. Harder. 1999. Human beta-defensin-2. Int. J. Biochem. Cell Biol. 31:645-651.
391. Schroeder, H. E. 1991. Oral structural biology. Thieme Medical Publishers, Inc., New York, N.Y.
392. Schuman, P., J. D. Sobel, S. E. Ohmit, K. H. Mayer, C. C. Carpenter, A. Rompalo, A. Duerr, D. K. Smith, D. Warren, R. S. Klein, and HIV Epidemiology Research Study (HERS) Group. 1998. Mucosal candidal colonization and candidiasis in women with or at risk for human immunodeficiency virus infection. Clin. Infect. Dis. 27:1161-1167.
393. Seguier, S., G. Godeau, and N. Brousse. 2000. Immunohistological and morphometric analysis of intra-epithelial lymphocytes and Langerhans cells in healthy and diseased human gingival tissues. Arch. Oral Biol. 45:441-452.
394. Seguier, S., G. Godeau, M. Leborgne, G. Pivert, and N. Brousse. 2000. Quantitative morphological analysis of Langerhans cells in healthy and diseased human gingiva. Arch. Oral Biol. 45:1073-1081.
395. Seibel, W. 1988. Basic tissues, p. 969. In D. V. Provenza (ed.), Fundamentals of oral histology and embryology. Lea & Febiger Philadelphia, Pa.
396. Selvanayagam, P., G. Lei, T. Bell, S. Ram, H. Brysk, S. Rajaraman, and M. M. Brysk. 1998. Desquamin is an epidermal ribonuclease. J. Cell. Biochem. 68:74-82.
397. Seney, F. D., Jr., D. K. Burns, and F. G. Silva. 1990. Acquired immunodeficiency syndrome and the kidney. Am. J. Kidney Dis. 16:1-13.
398. Sepkowitz, K. A. 1998. Effect of HAART on natural history of AIDS-related opportunistic disorders. Lancet 351:228-230.
399. Shannon, R. P. 2001. SIV cardiomyopathy in non-human primates. Trends Cardiovasc: Med. 11:242-246.
400. Shannon, R. P., M. A. Simon, M. A. Mathier, Y. J. Geng, S. Mankad, and A. A. Lackner. 2000. Dilated cardiomyopathy associated with simian AIDS in nonhuman primates. Circulation 101:185-193.
401. Sherwood, J., N. A. Gow, G. W. Gooday, D. W. Gregory, and D. Marshall. 1992. Contact sensing in Candida albicans: a possible aid to epithelial penetration. J. Med. Vet. Mycol. 30:461-469.
402. Shojaei, A. H. 1998. Buccal mucosa as a route for systemic drug delivery: a review. J. Pharm. Pharm. Sci. 1:15-30.
403. Simard, M. C., P. Chrobak, D. G. Kay, Z. Hanna, S. Jothy, and P. Jolicoeur. 2002. Expression of simian immunodeficiency virus nef in immune cells of transgenic mice leads to a severe AIDS-like disease. J. Virol. 76:3981-3995.
404. Skowronski, J., D. Parks, and R. Mariani. 1993. Altered T cell activation and development in transgenic mice expressing the HIV-1 nef gene. EMBO J. 12:703-713.
405. Sobel, J. D., S. E. Ohmit, P. Schuman, R. S. Klein, K. Mayer, A. Duerr, J. A. Vazquez, and A. Rampalo. 2001. The evolution of Candida species and fluconazole susceptibility among oral and vaginal isolates recovered from human immunodeficiency virus (HIV)-seropositive and at-risk HIV-sero-negative women. J. Infect. Dis. 183:286-293.
406. Sohnle, P. G., M. J. Hunter, B. Hahn, and W. J. Chazin. 2000. Zinc-reversible antimicrobial activity of recombinant calprotectin (migration inhibitory factor-related proteins 8 and 14). J. Infect. Dis. 182:1272-1275.
407. Soukka, T., J. Tenovuo, and M. Lenander-Lumikari. 1992. Fungicidal effect of human lactoferrin against Candida albicans. FEMS Microbiol. Lett. 69:223-228.
408. Sozzani, S., P. Allavena, A. Vecchi, and A. Mantovani. 2000. Chemokines and dendritic cell traffic. J. Clin. Immunol. 20:151-160.
409. Spellberg, B. and J. E. Edwards, Jr. 2001. Type 1/type 2 immunity in infectious diseases. Clin. Infect. Dis. 32:76-102.
410. Sporri, B., J. von Overbeck, C. U. Brand, J. Schmidli, M. L. Sanchez, R. Grunow, and L. R. Braathen. 1994. Reduced number of Langerhans cells in oral mucosal washings from HIV-1 seropositives. J. Oral Pathol. Med. 23:399-402.
411. Squier, C. A., and M. J. Kremer. 2001. Biology of oral mucosa and esophagus. J. Natl. Cancer Inst. Monogr. 29:7-15.
412. Staib, P., M. Kretschmar, T. Nichterlein, H. Hof, and J. Morschhauser. 2000. Differential activation of a Candida albicans virulence gene family during infection. Proc. Natl. Acad. Sci. USA 97:6102-6107.
413. Steele, C., and P. L. Fidel, Jr. 2002. Cytokine and chemokine production by human oral and vaginal epithelial cells in response to Candida albicans. Infect. Immun. 70:577-583.
414. Steele, C., J. Leigh, R. Swoboda, and P. L. Fidel, Jr. 2000. Growth inhibition of Candida by human oral epithelial cells. J. Infect. Dis. 182:1479-1485.
415. Steele, C., J. Leigh, R. Swoboda, H. Ozenci, and P. L. Fidel, Jr. 2001. Potential role for a carbohydrate moiety in anti-Candida activity of human oral epithelial cells. Infect. Immun. 69:7091-7099.
416. Steidley, K. E., S. H. Thompson, M. J. McQuade, S. L. Strong, M. J. Scheidt, and T. E. Van Dyke. 1992. A comparison of T4:T8 lymphocyte ratio in the periodontal lesion of healthy and HIV-positive patients. J. Periodontol. 63:753-756.
417. + lymphocyte cell enumeration for prediction of clinical course of human immunodeficiency virus disease: a review. J. Infect. Dis. 165:352-363.
418. Steinhoff, M., T. Brzoska, and T. A. Luger. 2001. Keratinocytes in epidermal immune responses. Curr. Opin. Allergy Clin. Immunol. 1:469-476.
419. Steinman, R. M. 2000. DC-SIGN: a guide to some mysteries of dendritic cells. Cell 100:491-494.
420. Stephens, E. B., C. Tian, S. B. Dalton, and V. H. Gattone. 2000. Simian-human immunodeficiency virus-associated nephropathy in macaques. AIDS Res. Hum. Retroviruses 16:1295-1306.
421. Strauss, J., C. Abitbol, G. Zilleruelo, G. Scott, A. Paredes, S. Malaga, B. Montane, C. Mitchell, W. Parks, and V. Pardo. 1989. Renal disease in children with the acquired immunodeficiency syndrome. N. Engl. J. Med. 321:625-630.
422. Stuchell, R. N., and I. D. Mandel. 1983. A comparative study of salivary lysozyme in caries-resistant and caries-susceptible adults. J. Dent. Res. 62:552-554.
423. Subauste, C. S., M. Wessendarp, A. G. Smulian, and P. T. Frame. 2001. Role of CD40 ligand signaling in defective type 1 cytokine response in human immunodeficiency virus infection. J. Infect. Dis. 183:1722-1731.
424. Sugiyama, Y., S. Nakashima, F. Mirbod, H. Kanoh, Y. Kitajima, M. A. Ghannoum, and Y. Nozawa. 1999. Molecular cloning of a second phospholipase B gene, caPLB2, from Candida albicans. Med. Mycol. 37:61-67.
425. Sullivan, D., K. Haynes, J. Bille, P. Boerlin, L. Rodero, S. Lloyd, M. Henman, and D. Coleman. 1997. Widespread geographic distribution of oral Candida dubliniensis strains in human immunodeficiency virus-infected individuals. J. Clin. Microbiol. 35:960-964.
426. Sweet, S. P., S. Cookson, and S. J. Challacombe. 1995. Candida albicans isolates from HIV-infected and AIDS patients exhibit enhanced adherence to epithelial cells. J. Med. Microbiol. 43:452-457.
427. Sweet, S. P., A. N. Denbury, and S. J. Challacombe. 2001. Salivary calprotectin levels are raised in patients with oral candidiasis or Sjogren's syndrome but decreased by HIV infection. Oral Microbiol. Immunol. 16:119-123.
428. Sweet, S. P., D. Rahman, and S. J. Challacombe. 1995. IgA subclasses in HIV disease: dichotomy between raised levels in serum and decreased secretion rates in saliva. Immunology 86:556-559.
429. Taniuchi, I., M. J. Sunshine, R. Festenstein, and D. R. Littman. 2002. Evidence for distinct CD4 silencer functions at different stages of thymocyte differentiation. Mol. Cell 10:1083-1096.
430. Tascini, C., F. Baldelli, C. Monari, C. Retini, D. Pietrella, D. Francisci, F. Bistoni, and A. Vecchiarelli. 1996. Inhibition of fungicidal activity of polymorphonuclear leukocytes from HIV-infected patients by interleukin (IL)-4 and IL-10. AIDS 10:477-483.
431. Tavitian, A., J. P. Raufman, and L. E. Rosenthal. 1986. Oral candidiasis as a marker for esophageal candidiasis in the acquired immunodeficiency syndrome. Ann. Intern. Med. 104:54-55.
432. Telenti, A., and R. G. Paolo. 2000. Limits to potent antiretroviral therapy. Rev. Med. Virol. 10:385-393.
433. Tenner-Racz, K., and P. Racz. 1995. Follicular dendritic cells initiate and maintain infection of the germinal centers by human immunodeficiency virus. Curr. Top. Microbiol. Immunol. 201:141-159.
434. Tenner-Racz, K., P. Racz, M. Bofill, A. Schulz-Meyer, M. Dietrich, P. Kern, J. Weber, A. J. Pinching, F. Veronese-Dimarzo, M. Popovic, et al. 1986. HTLV-III/LAV viral antigens in lymph nodes of homosexual men with persistent generalized lymphadenopathy and AIDS. Am. J. Pathol. 123:9-15.
435. Teunissen, M. B., C. W. Koomen, M. R. de Waal, E. A. Wierenga, and J. D. Bos. 1998. Interleukin-17 and interferon-gamma synergize in the enhancement of proinflammatory cytokine production by human keratinocytes. J. Investig. Dermatol. 111:645-649.
436. Teunissen, M. B., H. A. Rongen, and J. D. Bos. 1994. Function of adhesion molecules lymphocyte function-associated antigen-3 and intercellular adhesion molecule-1 on human epidermal Langerhans cells in antigen-specific T cell activation. J. Immunol. 152:3400-3409.
437. Tinkle, B. T., H. Ueda, L. Ngo, P. A. Luciw, K. Shaw, C. A. Rosen, and G. Jay. 1997. Transgenic dissection of HIV genes involved in lymphoid depletion. J. Clin. Investig. 100:32-39.
438. Tohyama, M., Y. Shirakara, K. Yamasaki, K. Sayama, and K. Hashimoto. 2001. Differentiated keratinocytes are responsible for TNF-alpha regulated production of macrophage inflammatory protein 3alpha/CCL20, a potent chemokine for Langerhans cells. J. Dermatol. Sci. 27:130-139.
439. Tomee, J. F., P. S. Hiemstra, R. Heinzel-Wieland, and H. F. Kauffman. 1997. Antileukoprotease: an endogenous protein in the innate mucosal defense against fungi. J. Infect. Dis. 176:740-747.
440. Tsai, H., and L. A. Bobek. 1998. Human salivary histatins: promising antifungal therapeutic agents. Crit Rev. Oral Biol. Med. 9:480-497.
441. Tumbarello, M., E. Tacconelli, D. K. de Gaetano, G. Morace, G. Fadda, and R. Cauda. 1999. Candidemia in HIV-infected subjects. Eur. J. Clin. Microbiol. Infect. Dis. 18:478-483.
442. Tylenda, C. A., J. Larsen, C. K. Yeh, H. C. Lane, and P. C. Fox. 1989. High levels of oral yeasts in early HIV-1 infection. J. Oral Pathol. Med. 18:520-524.
443. Uchi, H., H. Terao, T. Koga, and M. Furue. 2000. Cytokines and chemokines in the epidermis. J. Dermatol. Sci. 24(Suppl. 1):S29-S38.
444. Van Dyke, R. B., S. Lee, G. M. Johnson, A. Wiznia, K, Mohan, K. Stanley, E. V. Morse, P. A. Krogstad, and S. Nachman. 2002. Reported adherence as a determinant of response to highly active antiretroviral therapy in children who have human immunodeficiency virus infection. Pediatrics 109:61.
445. van Loon, L. A., S. R. Krieg, C. L. Davidson, and J. D. Bos. 1989. Quantification and distribution of lymphocyte subsets and Langerhans cells in normal human oral mucosa and skin. J. Oral Pathol. Med. 18:197-201.
446. Van Wijngaerden, E., S. De, V, G. De, V, A. M. Vandamme, K. Van Vaerenbergh, H. Bobbaers, A. Deschamps, H. Ceunen, and S. De Geest. 2002. Nonadherence to highly active antiretroviral therapy: clinically relevant patient categorization based on electronic event monitoring. AIDS Res. Hum. Retroviruses 18:327-330.
447. Vargas, K., S. A. Messer, M. Pfaller, S. R. Lockhart, J. T. Stapleton, J. Hellstein, and D. R. Soll. 2000. Elevated phenotypic switching and drug resistance of Candida albicans from human immunodeficiency virus-positive individuals prior to first thrush episode. J. Clin. Microbiol. 38:3595-3607.
448. Vargas, K. G., and S. Joly. 2002. Carriage frequency, intensity of carriage, and strains of oral yeast species vary in the progression to oral candidiasis in human immunodeficiency virus-positive individuals. J. Clin. Microbiol. 40:341-350.
449. Vazquez-Torres, A., and E. Balish. 1997. Macrophages in resistance to candidiasis. Microbiol. Mol. Biol. Rev. 61:170-192.
450. Vudhichamnong, K., D. M. Walker, and H. C. Ryley. 1982. The effect of secretory immunoglobulin A on the in-vitro adherence of the yeast Candida albicans to human oral epithelial cells. Arch. Oral Biol. 27:617-621.
451. Wagner, D. K., and P. G. Sohnle. 1995. Cutaneous defenses against dermatophytes and yeasts. Clin. Microbiol. Rev. 8:317-335.
452. Wagner, R. D., A. Vazquez-Torres, J. Jones-Carson, T. Warner, and E. Balish. 1996. B cell knockout mice are resistant to mucosal and systemic candidiasis of endogenous origin but susceptible to experimental systemic candidiasis. J. Infect. Dis. 174:589-597.
453. Walsh, T. J., C. E. Gonzalez, S. Piscitelli, J. D. Bacher, J. Peter, R. Torres, D. Shetti, V. Katsov, K. Kligys, and C. A. Lyman. 2000. Correlation between in vitro and in vivo antifungal activities in experimental fluconazole-resistant oropharyngeal and esophageal candidiasis. J. Clin. Microbiol. 38:2369-2373.
454. Walsh, T. J., and W. G. Merz. 1986. Pathologic features in the human alimentary tract associated with invasiveness of Candida tropicalis. Am. J. Clin. Pathol. 85:498-502.
455. Ward, P. P., S. Uribe-Luna, and O. M. Conneely. 2002. Lactoferrin and host defense. Biochem. Cell Biol. 80:95-102.
456. Weinberg, A., S. Krisanaprakornkit, and B. A. Dale. 1998. Epithelial antimicrobial peptides: review and significance for oral applications. Crit. Rev. Oral Biol. Med. 9:399-414.
457. Wenisch, C., B. Parschalk, K. Zedwitz-Liebenstein, W. Graninger, and A. Rieger. 1996. Dysregulation of the polymorphonuclear leukocyte-Candida spp. interaction in HIV-positive patients. AIDS 10:983-987.
458. Wertz, P. W., and C. A. Squier. 1991. Cellular and molecular basis of barrier function in oral epithelium. Crit. Rev. Ther. Drug Carrier Syst. 8:237-269.
459. White, T., G. A. Kohler, S. H. Miyasaki, and N. Agabian. 1995. Expression of virulence factors in Candida albicans. Can. J. Bot. 73:1058-1064.
460. Wingens, M., B. H. van Bergen, P. S. Hiemstra, J. F. Meis, I. M. Vlijmen-Willems, P. L. Zeeuwen, J. Mulder, H. A. Kramps, F. van Ruissen, and J. Schalkwijk. 1998. Induction of SLPI (ALP/HUSI-I) in epidermal keratinocytes. J. Investig. Dermatol. 111:996-1002.
461. Winzler, C., P. Revere, M. Rescigno, F. Granucci, G. Penna, L. Adorini, V. S. Zimmermann, J. Davoust, and P. Ricciardi-Castagnoli. 1997. Maturation stages of mouse dendritic cells in growth factor-dependent long-term cultures. J. Exp. Med. 185:317-328.
462. Wira, C. R., and R. M. Rossoll. 1995. Antigen-presenting cells in the female reproductive tract: influence of the estrous cycle on antigen presentation by uterine epithelial and stromal cells. Endocrinology 136:4526-4534.
463. Wood, G. S., N. L. Warner, and R. A. Warnke. 1983. Anti-Leu-3/T4 antibodies react with cells of monocyte/macrophage and Langerhans lineage. J. Immunol. 131:212-216.
464. Wozniak, K. L., J. E. Leigh, S. Hager, R. K. Swoboda, and P. L. Fidel, Jr. 2002. A comprehensive study of Candida-specific antibodies in the saliva of human immunodeficiency virus-positive individuals with oropharyngeal candidiasis. J. Infect. Dis. 185:1269-1276.
465. Wu, T., L. P. Samaranayake, B. Y. Cao, and J. Wang. 1996. In-vitro proteinase production by oral Candida albicans isolates from individuals with and without HIV infection and its attenuation by antimycotic agents. J. Med. Microbiol. 44:311-316.
466. Xu, J., T. M. Foy, J. D. Laman, E. A. Elliott, J. J. Dunn, T. J. Waldschmidt, J. Eisernere, R. J. Noelle, and R. A. Flavell. 1994. Mice deficient for the CD40 ligand. Immunity 1:423-431.
467. Yang, D., O. Chertov, S. N. Bykovskaia, Q. Chen, M. J. Buffo, J. Shogan, M. Andersen, J. M. Schroder, J. M. Wang, O. M. Howard, and J. J. Oppenheim. 1999. Beta-defensins: linking innate and adaptive immunity through dendritic and T cell CCR6. Science 86:525-528.
468. Yang, D., O. Chertov, and J. J. Oppenheim. 2001. Participation of mammalian defensins and cathelicidins in anti-microbial immunity: receptors and activities of human defensins and cathelicidin (LL-37). J. Leukoc. Biol. 69:691-697.
469. Yeh, C. K., M. W. Dodds, P. Zuo, and D. A. Johnson. 1997. A population-based study of salivary lysozyme concentrations and candidal counts. Arch. Oral Biol. 42:25-31.
470. Yeh, C. K., P. C. Fox, J. A. Ship, K. A. Busch, D. K. Bermudez, A. M. Wilder, R. W. Katz, A. Wolff, C. A. Tylenda, and J. C. Atkinson. 1988. Oral defense mechanisms are impaired early in HIV-1 infected patients. J. Acquir. Immune. Defic. Syndr. 1:361-366.
471. + bone marrow hematopoietic progenitor cells. Blood 92:118-128.
472. Zhang, Y., Y. Y. Zhang, M. Ogata, P. Chen, A. Harada, S. Hashimoto, and K. Matsushima. 1999. Transforming growth factor-β1 polarizes murine hematopoietic progenitor cells to generate Langerhans cell-like dendritic cells through a monocyte/macrophage differentiation pathway. Blood 93: 1208-1220.
473. Zingman, B. S. 1996. Resolution of refractory AIDS-related mucosal candidiasis after initiation of didanosine plus saquinavir. N. Engl. J. Med. 334:1674-1675.
474. Zon, L. I., C. Arkin, and J. E. Groopman. 1987. Haematologic manifestations of the human immune deficiency virus (HIV). Br. J. Haematol. 66:251-256.